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Abstract 
 
The investigation was aimed to improve the understanding of the binding interactions 
between DevS and DevR that are implicated in the regulation of the dormancy response in 
Mycobacterium tuberculosis. These binding interactions could provide good drug targets for 
the treatment of persistent tuberculosis, the mechanistic understanding of their binding 
interactions is important for the development of a validated inhibitor screen. A detailed in 
silico analysis of the amino acid residues that play a role in the binding of receptor DevR to 
both kinase DevS and the target DNA was undertaken. A reasonable approximation of the 
DevS structure was produced using homologous protein structures. In silico docking of DevS 
to DevR merely produced a set of probable candidate structures, since more than one 
conformation with similar docked energies was observed. The decision on which one is the 
more correct form can only be estimated by crystallization of this complex. Therefore, the 
functional expression and purification of the Dev TCS components were pursued. Denaturing 
HIS™-select nickel affinity gel purification in the form of matrix-assisted refolding led to the 
production of functional Dev TCS proteins. To understand the binding of DevR to DNA 
consensus sequences, as well as the nature of these interactions, a model was built of the full 
length DevR dimer binding to DNA consensus sequences. Based on this model, single 
mutations were made to DevR in vitro and their effects assessed in order to validate the 
model built. During Electrophoretic Mobility Shift Assay (EMSA) analysis, it was found that 
K179I and N183L mutants prevented the binding of DevR to the DNA consensus sequences. 
If DevR and DevS binding are to be used in a drug development program, it is essential to 
have the protocols to accurately measure their interaction, in addition to developing a 
fundamental understanding of how their interactions occur. The binding affinity of DevR to 
both DevS and the truncated soluble fragment of DevS (DevS201) were explored, using the 
BIAcore instrument, an SPR-based biosensor. For sufficiently strong binding between a 
histidine kinase and a response regulator, the KD needs to be in the nM range. The KD was 
calculated to be 255 nM for DevS201 and 184 nM for DevS. Therefore it can be concluded 
that DevS201 binds DevR strongly enough to be used in future studies, and that the BIAcore 
could be used to screen small-molecule inhibitors of DevR-DevS interactions.  
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Opsomming 
  
Die Dev twee komponent sisteem (TKS) bestaan uit ‘n histidine kinase naamlik (DevS) en ‘n 
reaksie reguleerder DevR. DevS en DevR is betrokke by die regulering van die dormante 
stadium van Mycobacterium tuberculosis. Hierdie meganisme kan ‘n deurbraak dwelm teiken 
vir die behandeling van sluimerende tuberkulose wees. Die meganisme van hierdie bindings 
interaksies is van kritieke belang, tesame met die ontwikkeling van 'n erkende inhibeerder 
toets.  ‘n Gedetaileerde in silico analise van die aminosuur volgordes wat 'n rol speel in die 
binding van die reseptor DevR aan beide DevS sowel as die teiken DNS is voltooi. ‘n Model 
van die DevS struktuur is saamgstel met behulp van homoloë proteïen strukture. In silico 
mering van DevS aan DevR het `n stel van die waarskynlike kandidaat strukture verskaf, 
aangesien meer as een konformasie met soortgelyke merings energieë waargeneem is. Die 
mees waarskynlike vorm kan alleenlik geïndentifiseer word na kristallisasie van hierdie 
kompleks. Die funksionele uitdrukking en suiwering van die Dev TKS proteine is gevolglik 
uitgevoer. Funksionele Dev TKS proteïene is verkry deur denaturerende HIS-select nikkel 
affiniteit jel suiwering, in die vorm van matriks-geassisteerde hervouing te gebruik.  
Ten einde die binding te verstaan tussen DevR en DNS konsensus volgordes, sowel as die 
aard van hierdie interaksies, is 'n model gebou van die volle lengte DevR dimeer binding aan 
DNS konsensus volgordes. Hierdie model is gevalideer deur punt mutasies in DevR  te skep 
en die gevolge daarvan te beoordeel met elektroforetiese mobiliteits verskuiwing reaksie 
analises. Dit is bevind dat K179I en N183L mutante, verhoed die binding van DevR aan die 
DNS konsensus volgordes. 
Die gebruik van DevR en DevS bindings in ‘n dwelm ontwikkelingsprogram, benodig die 
fundamentele begrip van hoe die interaksies plaasvind,  sowel as akkurate protokolle om die 
interaksies te meet. Die BIAcore instrument, ’n SPR-gebaseerde biosensor, is ingespan om 
die bindings affiniteit van DevR aan beide DevS en die fragment van DevS (DevS201) te 
ondersoek. Om voldoende sterk binding tussen DevS en die DevR te verseker, moet die KD 
in die nM omgewing wees.  Die KD is bepaal as 255 nM en 184 nM vir DevS201 en DevS, 
onderskeidelik. Die afleiding kan dus gemaak word dat DevS201 sterk genoeg aan DevR 
bind om in verdere studies gebruik te kan word, en dat die BIAcore gebruik kan word om 
klein-molekule inhibeerders van DevR-DevS interaksies te toets. 
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Chapter 1 Literature Review  
 
 
 
“Today we are calling on the world to recognize that we can't fight HIV unless we do much 
more to fight TB as well.” 
 
- President Nelson Mandela 
 
 
1.1 Mycobacterium genus.  
 
The genus Mycobacterium includes several medically-important species that cause a high 
degree of human morbidity and mortality. Mycobacterium tuberculosis (M. tb) is estimated 
by the World Health Organization (www.who.org) to affect almost one third of the world 
population. The genus is divided into slow growers and fast growers, taking either more or 
less than 7 days to form colonies on selected media, respectively. Based on a high degree of 
genetic similarity, a number of these species can be grouped into complexes that will also 
cause similar disease syndromes (Saviola and Bishai, 2006). The Mycobacterium tuberculosis 
complex is comprised of M. tb, M. bovis, M. microti and M. africanum. and M. bovis are most 
prevalent in humans, while M. africanum is found in patient isolates collected from Africa 
(Shinnick and Good, 1994). M. bovis is known for its attenuated vaccine strain Bacilli 
Calmette Guerin (BCG) (Saviola and Bishai, 2006). The Mycobacterium avium complex 
consists of M. avium, M. intracellulare and M. paratuberculosis, commonly found in the 
environment and isolated from soil, water and food (Havlir and Ellner, 2000). Chickens, 
pigeons and other birds can show tuberculosis-like symptoms caused by an infection of M. 
avium, whereas M. paratuberculosis infects ruminants to cause related symptoms called 
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Johne’s disease (Scanu et al., 2007). M. leprae, another example of a slow growing 
Mycobacterium species, causes leprosy, recognized by the bodily deformities that are 
symptomatic to the disease (Gelber et al., 2009). M. marinum, closely related to the M. tb 
complex, produces cutaneous lesions such as swimming pool granuloma or fish handler’s 
nodule. Since the reservoir for M. marinium is water, humans become infected via 
environmental water, handling fish or during the cleaning and maintenance of fish tanks 
(Toosi and Ellner, 1998).  
1.2 Tuberculosis 
 
Tuberculosis (TB) is caused by M. tb - one of the most dreaded human pathogens. TB is still 
a primary cause of death in low- and middle-income countries, particularly in sub-Saharan 
Africa where people have an increased vulnerability conferred by Human Immunodeficiency 
Virus (HIV) infection and the acceleration in the emergence of drug resistant M. tb strains 
(World Health Organization report, 2006). Multidrug resistant (MDR) tuberculosis is 
resistant to rifampicin and isoniazid (frontline drugs), with or without other resistance 
(Maartens and Wilkinson, 2007). Extensively drug resistant (XDR) tuberculosis is resistant to 
at least rifampicin and isoniazid, in addition to any quinolone and at least one injectable 
second line agent such as capreomycin, amikacin or kanamycin (Maartens and Wilkinson, 
2007). In 2007, the World Health Organization estimated that there were approximately 9 
million new TB cases, which was higher than the estimated 8.24 million new cases in 2006. 
India and China had the highest incidence rates, as can be seen in Figure 1.1, followed by 
South Africa, Nigeria and Indonesia. In terms of total number of cases, India ranked first with 
2.0 million, before China (1.3 million), Indonesia (0.53 million), Nigeria (0.49 million) and 
South Africa (0.46 million). Countries like Russia, Ethiopia, Kenya, Zaire, Uganda, Tanzania 
and Zimbabwe also fall in this high prevalence group, as seen in Figure 1.1. 
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Figure 2.1: The estimated new TB infections (incidence) of all forms per country. The countries with a low incidence 
are indicated in shades of grey, countries with high incidence are indicated in shades of red. India and Indonesia has the 
highest incidence. WHO estimates that 9.27 million new cases of TB occurred in 2007 (139 per 100,000 population), this is 
higher compared with 8.24 million new cases (140 per 100,000 population) in 2006. (World Health Organization report, 
2007). 
 
It was estimated that 23% of total deaths of people infected with M. tb can be attributed to co-
infection with HIV, equivalent to 465,000 deaths amongst HIV-positive people and a total of 
1.3 million deaths among HIV-negative people in 2007 (WHO Report, 2009). The increasing 
numbers of new cases can be ascribed to drug resistance, co-infection with HIV, urban 
crowding, international travel and migration, as well as poverty, poor infection control 
policies and inadequate drug treatment regimens. Contributing to these factors are the 
difficulties encountered during the diagnosis and treatment of children, especially in third 
world countries (Fätkenheuer et al., 1999). It has become evident that only an attempt to fight 
TB and HIV simultaneously will have an impact on disease management (Corbett et al., 
2003). 
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1.3 Mycobacterium tuberculosis infection 
 
When a person with an active M. tb infection coughs, the bacteria spread via the aerosols 
produced. After these infectious bacilli are localized in the lungs (primary site of infection) 
and various disease outcomes are then possible (Cosma et al., 2003). Most people who are 
exposed to the tuberculosis bacilli have an innate protection and will never show any sign of 
infection (Parish et al., 1999). In a small proportion of people the bacilli will actively 
multiply and the host will develop the active disease. Following infection, bacilli reside 
inside the macrophages in the lung. If the host’s immune system does not eradicate the 
bacterium, M. tb will adapt to the hostile environment within the macrophage and start to 
replicate. Typically, during most other bacterial infections, the invading bacterium will be 
destroyed within the phagosome via acidification of the phagosome after fusion with the 
lysosome (Fisher et al., 2002). Destruction of the bacilli should occur because of the lytic 
enzymes present in the lysosome, as well as the sterilizing effect of the production of reactive 
oxygen intermediates (ROI) (Clemens and Horwitz, 1995).  
In contrast, M. tb-containing phagosomes resist acidification as well as lysosomal fusion. M. 
tb arrests the maturation of its phagosome at the stage where the phagosome has the 
characteristics of early and late endosomes but not the characteristics of a lysosome 
(Schnappinger et al., 2003). This leads to the evasion of the first line of defence of the host 
immune system by the M. tb bacilli. 
For this reason, a portion of people will harbour a dormant infection that is a constant source 
of reactivation disease (Corbett et al., 2003). During latent infection, the bacilli are 
suppressed, the host does not develop the active disease and consequently the bacteria avoid 
being eliminated. When the host immune system fails to keep the bacilli in check, the 
infection will be reactivated and cause active disease (Flynn and Chan, 2001). The threat of 
M.tb lies in its ability to revert to asymptomatic latent infections that serves as a reservoir for 
future infections. 
Current treatment of latent tuberculosis is not as effective as active TB treatment because of 
the latent bacilli’s low metabolic state. Failure to treat both active and latent tuberculosis will 
hamper the progress in global eradication of the disease (Voskuil et al., 2004)  
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1.4 Mycobacterium tuberculosis: The dormant stage and dormancy regulon  
 
The non-proliferating stage of M. tb infection is referred to as the stationery phase, latency, 
dormancy or persistence (Zahrt and Deretic, 2000; Rhen et al., 2003). The metabolic and 
replicative status during this dormant phase is not clear. M. tb does not form true spores like 
B. subtilis nor does it go into a non–differentiating stage like E. coli. Furthermore, M. tb 
dormancy is not driven by starvation conditions but rather by hypoxic conditions and low 
nitric oxide (NO) concentrations (Voskuil et al., 2004). M. tb bacilli in this dormant state 
show a phenotypical resistance to anti-mycobacterial drugs, mainly because these drugs 
target growth-related functions (Boon and Dick, 2002). In order to replicate dormancy, 
experimental models are used and include exposure to low concentrations of oxygen and 
increased NO (Saini et al., 2004a). Voskuil et al. (2003) characterized a gene set of 48 genes 
that are up-regulated when M. tb enters into a low oxygen and increased NO dormant state. 
These genes are in close proximity, indicating that this type of arrangement might support a 
fast, co-ordinated transcriptional response when dormancy is entered (Voskuil et al., 2003). It 
was demonstrated that this gene set failed to induce when the devR gene was disrupted, and 
the set was labelled the “dormancy regulon” (Park et al., 2003). Most of the genes identified 
were conserved hypothetical proteins, but this dormancy regulon also included enzymes 
involved with glutamine and nitrate transport, as well as acyl-CoA dehydrogenase and a 
resuscitation promoting factor (Kendall et al., 2004).  
1.5 Two-component signal transduction systems in Prokaryotes  
 
Pathogen survival is based on the capacity of pathogens to express no more than those gene 
products necessary for the optimal growth in their ever-changing environment. Prokaryotes 
have developed complex adaptation machineries to survive in various ecological niches, one 
of which is the two-component signal transduction system (Beier and Gross, 2006). Currently 
approximately 4,000 bacterial two-component systems (TCSs) have been identified in 145 
sequenced genomes (Ulrich et al., 2005). The TCSs, which function by means of histidine 
phosphorylation, are a critical component of prokaryotic cell signalling and are also found in 
lower eukaryotes. TCSs consist typically of a membrane-bound sensor with histidine kinase 
(HK) activity and a cytoplasmic response regulator (West and Stock, 2001). Bacterial and 
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archaeal species make use of this signalling process. Response regulators make up 
approximately 23% of all encoded proteins of 200 completely sequenced genomes (Galperin, 
2006). The basic biochemistry of the TCS starts with the sensor kinase’s capability to 
recognize the change in the environment, autophosphorylation and subsequent 
phosphorylation of a specific response regulator, as seen in Figure 1.2. The HK protein is 
phosphorylated at a conserved histidine located in the kinase domain of the protein. 
Phosphotransfer occurs between the phosphorylated-histidine on the HK to an aspartate 
residue on the response regulator protein (Figure 1.2). The regulatory domain of the response 
regulator changes conformation based on this phosphorylation, which alters the effector 
domain’s DNA binding properties (Beier and Gross, 2006; Puttick et al., 2008). Response 
regulators then activate the transcription of a number of genes that are specifically associated 
with survival (Grigoroudis et al., 2007). Despite their global presence and importance in 
bacteria, surprisingly little is known about the external stimuli that activate different systems 
and the subsets of genes that are affected. Examples of signals that can activate the kinase 
sensor include ions, pH, temperature, oxygen pressure, redox state, osmolarity and others 
(Beier and Gross, 2006).  
 
Figure 1.2: The two-component phosphotransfer scheme (Klumpp and Krieglstein 2002). A TCS typically consists of a 
dimeric transmembrane sensor histidine kinase and a cytoplasmic response regulator. The ATP-binding domain of the HK 
consists of approximately 250 amino acids and contains four conserved blocks of amino-acid sequences: N, G1 (or D), F and 
G2 (or G). Similarly, the Regulatory domain of the response regulator can be identified by the number and spacing of 
conserved aspartate, lysine, and hydrophobic residues. 
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1.6 The sensor histidine kinases 
 
Most members of the histidine kinase (HK) family have two functionally and structurally 
different segments: an N-terminal sensor domain and a C-terminal conserved domain 
(Wolanin et al., 2002). The sensing domains are variable in sequence, reflective of the many 
different environmental signals to which HKs are responsive, whereas the kinase core is more 
conserved (Galperin, 2006). The kinase core includes dimerization and ATP binding domains 
and can be identified by five conserved sequence motifs present in prokaryotic HKs (Stock et 
al., 1988). These motifs have been termed the H, N, G1 (or D), F and G2 (or G) boxes 
(Bilwes et al., 2001). The conserved histidine that gets phosphorylated is the central feature 
in the H box, whereas the N, D, F and G boxes define the ATP binding cleft (Marina et al., 
2001). In most HKs, the H box is part of the dimerization domain. However, for some 
proteins, like T. maritima CheA, the conserved histidine is located at the far N-terminus of 
the protein in a separate Histidine-containing phosphotransfer (PT) domain (Bilwes et al., 
2001). The N, G1, F and G2 boxes are usually contiguous, but the spacing between these 
motifs can be somewhat varied, as seen in Figure 1.3 and Figure 1.4. 
The work by Grebe and Stock (1999) identified 11 distinct sub-families of HKs, based in the 
outcome of multiple protein sequence alignments. Nevertheless, the sub-families all have the 
representative homology boxes. Figure 1.3 shows the alignment of a representative of each of 
the sub-families, indicating the presence of the relevant boxes. Kim and Forst (2001) also 
took a genomic approach to analyse the HK family in bacteria and archae, identifying the HK 
groups based on phylogenetic analysis and sequence similarity. They concluded that the HKs 
could be grouped into 5 different classes (Figure 1.4).  
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Figure 1.3: Protein sequence alignment of representatives of the 11 histidine kinase sub-families.  The conserved boxes and the motives they comprise are shaded. The dark pink indicates 
highly conserved residues. The other colours indicate residues that are more than 50% conserved in HK's. The alignment was adapted from Grebe and Stock, 1999. The numerals indicate the 
group to which the sequence belongs. Some groups have several sub-groups and this is indicated by the alphabetic character. Abbreviations of the species is used and the full names are found 
Appendix A.  
H-box N-box F-box G2-box G1-box 
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Figure 1.4: Alignment of the homology boxes of the HKs found in E. coli. The conserved motifs are shaded. The dark pink indicates highly conserved residues. The other colours indicate 
residues that are more than 50% conserved in HK's. The classification of each HK found in E. coli, is indicated by the numeral identifier and the sub-class is indicated by the alphabetic 
character. CheA is the only member of class 5. The alignment was adapted from Kim and Forst, 2001. 
H-box N-box F-box G2-box G1-box G3-box 
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1.7 Mycobacterium tuberculosis: two-component systems  
 
Tubercle bacilli survive and multiply in severe, hostile environments within the human host. 
To ensure survival, it is important for the bacilli to express different sets of genes at different 
stages of infection (Parish et al., 2003). M. tb contains 11 paired two-component HK signal 
transduction systems, as well as a few unpaired sensor kinases and orphan regulators (Haydel 
and Clark-Curtiss, 2004). A summary of these TCS is shown in Table 1.1. Two-component 
regulatory systems are usually encoded in operons that include both the sensor kinase and 
response regulator genes for co-expression of the corresponding proteins. This also decreases 
the chances of cross-talk between non-cognate sensors and regulators (Laub and Goulian, 
2007). In contrast, bacterial genomes often code for unpaired two-component system proteins 
where a sensor kinase gene is not accompanied by a response regulator gene and orphan 
regulators not accompanied by a sensor kinase (Raghavan and Groisman, 2010). Very little is 
known about the global regulatory mechanisms of M. tb that co-ordinate the gene expression 
after phagocytosis by the human macrophage, but M. tb initiates a latent infection that 
overcomes the defence reactions launched by the host cell (Rhen et al., 2003; Haydel and 
Clark-Curtiss, 2004). TCSs allow bacteria to sense and adapt to different environmental 
factors, and must assist M. tb to survive inside the macrophage in the presence of low 
oxygen, high NO, presence of reactive oxygen intermediates (ROIs), low iron concentration, 
pH differences and nutrient deprivation. Compared to bacteria like E.coli, B.subtilis and 
Streptococcus pneumonia, M. tb has relatively few TCSs (Fontan et al., 2004). The DevR-
DevS TCS, also referred to as DosR-DosS, is a two-component system of M. tb identified to 
play a significant role in the dormancy regulon (Park et al., 2003). DevS is the sensor kinase 
and DevR the response regulator. The Dev TCS was found to express at higher levels in a 
virulent strain compared to the avirulent strains (Dasgupta et al., 2000). Dev was named as 
“differentially expressed in virulence strain” and is also known as Dos for “dormancy 
survival regulator” (Gupta et al., 2009).    
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Table 1.1 The 11 paired two-component systems found in M. tuberculosis 
Kinase 
Sensor 
Response 
Regulator 
Output function 
PhoQ PhoP Perez et al. (2001) implicated the Pho TCS in virulence. In Salmonella 
typhimurium the PhoP-PhoQ system functions to detect cellular concentrations of 
Mg2+. PhoQ detects low Mg2+ concentration and PhoP will initiate expression of 
high affinity Mg2+ transport systems to assist the bacteria to overcome the Mg2+ 
starvation (Vescovi et al., 1997). The M. tb PhoP shows sequence similarity to 
S. typhimurium PhoP and a similar function can be inferred (Groisman, 2001). 
The specific genes under PhoP control have not been identified (Fontan et al., 
2004). 
 
KdpD KdpE The K+ uptake machinery in M. tb is believed to be under the control of the Kdp 
TCS (Altendorf et al., 1994). 
 
PrrB PrrA PrrA-PrrB assists the adaption of the bacilli during the early growth phase 
(Ewann et al., 2004). The PrrA–PrrB system belongs to a wide subfamily of 
TCSs, of which OmpR–EnvZ is the prototype (Ewann et al., 2004). 
 
MprB MprA This TCS plays a role in the establishment and maintenance of the persistent 
infection (Zahrt and Deretic, 2000). 
 
NarX  NarL M. tb NarL was classified as a putative nitrate response regulator involved in the 
control of anaerobic metabolism (Schnell et al., 2008). Protein sequence 
homology revealed that the closest sequence homologue to M. tb NarL was from 
E. coli. However, it displayed significant differences in three-dimensional 
structure (Schnell et al., 2008). 
 
MtrB MtrA Zahrt and Dieretic (2000) reported, that although the function of this TCS is still 
unknown, it is essential to M. tb because it is differentially expressed between 
virulent and avirulent mycobacterium strains during growth in macrophages and 
MtrA is induced in iron deficient conditions (Rodriguez et al., 2002). 
 
SenX RegX Clover et al. (2007) have recognized the SenX3-RegX3 TCS of M. smegmatis as 
a phosphate-dependent regulator of genes implicated in phosphate acquisition. 
The TCS is one of the five conserved Mycobacterium TCSs, suggesting that it 
plays a similar and important role in the survival of the mycobacterium in both 
virulent strains and avirulent strains (King-Scott et al., 2007). 
 
TrcS TrcR TrcS-TrcR mutations showed no phenotype in BALB/c mouse, but were 
hypervirulent in SCID mouse models (Parish et al., 2003; Ewann et al., 2004). 
The role this TCS plays in growth or virulence remains unknown. However, 
evidence was found that TrcR is involved in the repression of the Rv1057 -
propeller gene that is expressed during growth of M. tb within human 
macrophages (Haydel and Clark-Curtiss, 2006). 
 
0600c/ 
0601c/  
0602c 
(TcrA) 
Plays a role in the regulation of hypoxia in M.tb. However, the specific role is not 
known (Sherman et al., 2001). 
 
TcrY TcrX In a SCID mouse model, TcrY-TcrX mutants showed a hypervirulent phenotype 
(Parish et al., 2003). 
 
DevS DevR Responds to hypoxia and is required for survival (Boon and Dick, 2002). 
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1.8 Mycobacterium tuberculosis: Dev two-component system 
 
The M. tb Dev TCS is involved in the mechanism by which the bacterium enters dormancy 
when challenged with an increase of NO and hypoxia in the macrophage (Ioanoviciu et al., 
2007). Hypoxia, a condition of decreased oxygen availability at the cellular level, is alleged 
to be connected with the induction and persistence of dormancy during the latent stage. Other 
known signals that activate the Dev regulon are low iron and ethanol (Schnappinger et al., 
2003). The schematic of the organization of the Dev locus is shown in Figure 1.5. A stress or 
stimulus in the cellular environment leads to the autocatalytic phosphorylation of the histidine 
kinase (DevS), which in turn causes the phosphoryl group transfer between the HK and the 
response regulator, DevR. The activated DevR then induces the dormancy regulon (Park et 
al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Schematic of the organization of the Dev locus. A) Schematic of the genome organization of the 
M. tuberculosis Dev locus (Chauhan and Tyagi, 2008a). B) The DevT-DevS-DevR phosphotransfer scheme (Roberts et al., 
2004). Both DevS and DevT are sensor HKs, which get phosphorylated by ATP during autophosphorylation. The phosphate 
group then gets transferred to the response regulator DevR during trans-phosphorylation. The phosphorylated DevR can then 
bind DNA.  
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The two-step reaction takes place when the membrane-bound HK is autophosphorylated at 
conserved His395. During the second step, the response regulator DevR is phosphorylated 
from the histidine by transfer of the phosphoryl group to a conserved aspartic acid residue, 
Asp54. When the phosphorylation status of the DevR changes, it alters its affinity for DNA 
motifs present upstream of the target genes (Saini et al., 2004b). Roberts et al. (2004) 
hypothesized that DevR phosphorylation increases its affinity for a specific palindromic 
DNA sequence that precedes genes that are up-regulated during the hypoxic response (the 
dormancy regulon), switching on the transcription of these genes. DevT, an unpaired HK 
sensor, is co-transcribed with the DevR-DevS TCS, and has the ability to phosphorylate 
DevR as well. DevT is an alanine-valine-rich protein that belongs to the universal stress 
protein family found in various bacteria (Saini et al., 2002). DevS uses Mg2+ as divalent ion 
during autophosphorylation, whereas DevT utilizes both Mg2+and Ca2+. In contrast to devS 
transcription that is hypoxia responsive, the devT transcription levels were found not to be 
raised during hypoxia (Saini et al., 2004a). Malhotra et al. (2004) supported the principle that 
the function of the DevR-DevS TCS is linked to dormancy as it plays a less significant role in 
the early stages of the M. tb infection. The exact role DevT plays in M. tb infection remains 
unresolved (Malhorta et al., 2004; Saini et al., 2004b). It is not impossible to assume that 
DevT can also bind and phosphorylate DevR under the same or different environmental 
signals. Both DevT and DevS are heme-based O2 sensors with Kd values for oxygen of 26 
µM and 3 µM respectively (Sousa et al., 2007). This begs the question - why there are two 
kinase sensors for a single response regulator on the M. tb genome? Redundancy or a 
difference in physiological states could be a plausible explanation. However, the possibility 
exists that the difference in the affinity and kinetics of the sensors may be critical for an 
oxygen dose-dependent response needed under different conditions (Sousa et al., 2007).  M. 
tb bacilli housing gene deletions for devR and devS are incapable of initiating a response to 
hypoxic conditions, making the DevR-DevS system an appealing drug target for persistent 
infection (Voskuil et al., 2003; Malhorta et al., 2004). The inhibition of proteins involved in 
signal transduction has an added downstream effect since this will interfere with the 
functionality of the complete regulatory network controlled by the response regulator. One 
inhibitor will therefore have a pleiotropic effect (Gupta et al., 2009). Another reason that the 
Dev TCS may be a good drug target is the low homology the Dev proteins have to other 
enzymes, as well as their absence in invertebrates and vertebrates - hence, inhibition will not 
affect cellular function of its eukaryotic host (Dasgupta et al., 2000).  
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1.9 Other Mycobacterium dormancy response regulators  
 
DevR regulates universal stress protein expression and adaption during oxygen starvation in 
M. smegmatis (O’Toole et al., 2003). The M. smegmatis DevR exhibits a high sequence 
similarity and gene linkage to the response regulator found in M. tb. M. smegmatis DevR also 
supports adaptation and resistance to environmental stresses caused by oxygen starvation 
(O’Toole et al., 2003). To overcome experimental difficulties associated with M. tb, M. bovis 
BCG was used as a model organism to study whether DevR plays a role in the adaptation to 
hypoxic conditions (Boon and Dick, 2002). The DevS and DevR are co-transcribed in both 
M. tb and M. bovis BCG and the genes share a 99.8% sequence similarity (Cole et al., 1998; 
Dasgupta et al., 2000). The deletion of the DevR coding sequence resulted in the absence of 
other dormancy-induced proteins like alpha-crystallin, universal stress protein domain-
containing Rv2623 and cystathionine -synthase domain-containing Rv2626c. In contrast, the 
DevS HK deletion had a moderate effect on the response of the bacilli to the hypoxic 
conditions (Boon and Dick, 2002).  
The design of inhibitors to the DevS-DevR TCS as part of a drug design initiative relies on an 
understanding of the molecular interactions and component binding of this system 
 
1.10 Hypothesis  
 
We hypothesize that an investigation into both the protein-protein and the protein-DNA 
interactions of the Dev TCS, can improve our understanding of the detailed mechanism 
associated with M. tb latency and provide a good drug target for persistent tuberculosis. 
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1.11 Research objectives 
 
1. To present a detailed in silico analysis of the amino acid residues that play a role in 
the binding interactions of DevR and DevS. The in silico study will then be used to 
shed some light on the 3D structures of the components that have not yet been 
crystallized. 
2. To functionally express and purify all the components of the M. tb Dev two-
component system. 
3. To analyze the binding interactions between DevS and DevR in order to use these 
interactions as drug targets and consequently develop inhibitor screening 
methodologies. 
4. To identify the amino acids involved in the binding interaction between DevR and 
respective DNA fragments, to be used in future rational drug design strategies. 
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Chapter 2 Homology modelling and In 
silico binding analysis of the Dev two-
component system 
 
 
2.1 Introduction 
 
2.1.1 Molecular modelling 
 
The most common method of in silico protein modelling is knowledge-based modelling or 
homology modelling. This entails building a model based on known structures of proteins 
homologous to the target protein. These homologous template proteins are usually the same 
protein from a different organism or a protein that has the same function. The topology or 
fold of these proteins plays a vital part in structure prediction. Ultimately, the most important 
step in homology modelling is the amino acid sequence alignment between the target protein 
and the template proteins. This step is based in the assumption that the target protein and the 
template proteins have diverged from a common ancestor protein and will therefore have a 
similar 3D structure (Sander and Schneider, 1991). In other words, proteins with similar 
sequences will have similar structures (Marti-Renom et al., 2000). 
There are various algorithms that can be used for homology modelling; the two best known 
algorithms are SWISS MODEL (Schwede et al., 2003) and MODELLER (Sali and Blundell, 
1993). The MODELLER program was used in this study. MODELLER uses a method called 
spatial restraint satisfaction modelling, during which various restraints can be used to guide 
model building.  These restraints include bond angles, dihedral angles and stereochemistry. 
The MODELLER algorithm assumes that the aligned residues will have similar restraints and 
uses these restraints to build the model (Sali et al., 1993). Loop modelling is one of the most 
difficult tasks in homology modelling. A number of enzymes only differ by the length and 
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composition of their loops and consequently the loops are linked to the specificity of an 
enzyme (Marti-Renom et al., 2000). 
Homology modelling has certain limitations. Choosing valid template proteins and assigning 
a fold to the target proteins is very important because errors occur in the models when the 
template model shows insertions or deletions with respect to the modelled proteins. 
Misalignment during the sequence alignment of proteins with low sequence homology leads 
to errors in the side chain packing and interaction analysis. 
Model assessment is important when choosing the more correct form of the protein. Doing a 
fold comparison between the target model and the template model is one of the first steps. It 
is also important to check the basic stereochemistry of the model with a program like 
PROCHECK (Laskowski et al., 1993). Furthermore, molecular mechanics in the form of 
energy minimization can assist to discriminate between correctly and incorrectly folded 
proteins, for example the CHARMM force field for minimization. 
Another limitation that homology models have is the resolution. Unlike crystal structures, the 
resolution cannot always go down to atom level; homology higher than 70% is needed for 
that to be possible.   
 
2.1.2 Structural information of histidine kinases 
 
Sensor histidine kinases (HKs) are strictly defined as those enzymes that catalyze the transfer 
of the terminal phosphate group from ATP to a conserved histidine on the HK. This kinase 
must have an associate response regulator to which this phosphate group can be transferred, 
in order to catalyze another reaction, usually involving DNA binding (Kim and Forst, 2001).  
Literature shows that there are highly conserved sequence domains in kinase proteins, 
especially in the kinase domain (catalytic core) consisting of conserved H, N, G1 and G2 
boxes, and a more variable F-box (Stock et al., 2000). Grebe and Stock (1999) were the first 
authors to suggest the idea that there are different subclasses of HKs that have evolved 
independently of each other. They used extensive sequence database searches to identify a 
HK dataset for their study. Multiple sequence alignment using the sequence homology boxes, 
found on the C-terminal of the HKs, were used to classify these kinases into distinct 
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subfamilies (see Figure 1.3). Kim and Forst (2001) used a BLAST analysis of the genomic 
sequences of the kinase domains of EnvZ, CheA, NarZ, YehU and DcuS to create a HK 
dataset for analysis (see Figure 1.4). A phylogenetic analysis using the unweighted pair-group 
method with arithmetic means algorithm (UPGMA) was used to classify the HK dataset into 
subfamilies.  
The HK superfamily has been classified by various criteria, but none have been done using 
the three-dimensional structural data available. In a broader sense this study aimed to close 
the gap between sequence and structure for HKs. Therefore a summary of those two-
component systems with structural data on both the sensor kinase and the response regulator 
in the Brookhaven Protein Databank (PDB) was compiled and is shown in Table 2.1.  
More specifically the interaction analysis between DevS and DevR is important for this 
study. The number of available protein structures is far less than the number of known 
proteins. This shows that there are many more protein structures still to be elucidated. 
Computational modelling is used to fill the gap. The aim of this study was to perform in silico 
analysis of the interactions between homology-modelled DevS and DevR, in order to obtain 
models that may be used with confidence to guide initial experiments to probe the binding 
interactions of the Dev TCS. It is hoped that this knowledge may contribute to the 
identification of targets against latent tuberculosis.  
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Table 2.1: Two-component systems in bacteria with structural data available in the PDB database for both the 
histidine kinase and the corresponding response regulator 
 
Kinase
Sensor 
Response 
Regulator 
Output Function 
ArcB  ArcA E. coli ArcB phosphorylates ArcA in response to anaerobic conditions. A phosphoryl group is 
transferred from His292 in the kinase domain to Asp576 in the receiver domain and then His717 in 
the Hpt domain of ArcB. Asp54 of ArcA receives the phosphoryl group from the Hpt-domain 
(Mika en Hengge, 2005). (PDB ArcB: 1FR0, 1A0B, 2A0B) (PDB ArcA: 1XHE, 1XHF) 
CheA CheY 
CheB 
Phosphorylated CheA phosphorylates response regulator CheY or CheB and phosphorylated CheY 
interacts with the flagellar motor switch complex to induce rotation of the flagella, resulting in 
smooth swimming behaviour. Clockwise rotation of the flagella takes place in the absence of the 
CheY-P interaction (Dons et al., 2004). (PDB CheA: 1B3Q,1UOS,1I5N)(PDB CheY 3F7N, 
3FFT)(PDB CheB 1A2O, 1CHD) 
EnvZ OmpR EnvZ and OmpR are responsible for osmoregulation (Buckler et al., 2000). (PDB EnvZ 1BXD, 
1JOY) (PDB OmpR 2JPB) 
NarK NarL NarL was classified as a nitrate response regulator involved in the control of anaerobic metabolism 
(Schnell et al., 2008). (PDB NarK 1EZI)(PDB NarL 1ILH, 3EUL, 1JE8)   
NtrB  NtrC E. coli NtrB (NRII) phosphorylates the transcription factor nitrogen response regulator I (NtrC, 
NRI) for the control of nitrogen-regulated Ntr genes. (Ninfa et al., 1993) (PDB NtrB: 1RT2) (PDB 
NtrC: 1NTR).  
LuxP 
LuxQ 
LuxO LuxR 
 
Vibrio harveyi’s autoinducer-1 (A-1) binds to the periplasmic receptor LuxP LuxQ then 
phosphorylates LuxO which indirectly represses the transcriptional activator LuxR. (Sun et al., 
2004) (PDB LuxP/LuxQ complex: 2HJ9, 1ZHH) (PDB LuxQ: 2HJE) 
PhoQ PhoP Salmonella typhimurium PhoQ phosphorylates the transcription response regulator PhoP in 
response to stimuli upon phagocytosis, thereby promoting bacterial virulence. (Vescovi et al., 1997; 
Groisman, 2001) (PDB PhoQ: 1ID0, 2C2A, 1YAX) (PDB PhoP: 1MVO, 2EU6, 2EUB). 
PrrB PrrA M. tuberculosis two-component system of PrrB and PrrA has been shown to be induced upon 
macrophage phagocytosis and to be transiently required for the early stages of macrophage infection 
(Ewann et al., 2004).(PDB PrrA: 1YS6, 1YS7) (PDB PrrB: 1YSR, 1YS3) 
FixL FixJ Rhizobium FixL detects oxygen tension. Oxygen-free (deoxy-) FixL transfers a phosphoryl group to 
FixJ at low-oxygen tension whereas the oxygen-bound form is inactivated. FixJ is a transcriptional 
factor (Wang et al., 2006). (PDB FixL: 1D06, 1DRM) (PDB FixL: 1X3U, 1DCM, 1DSW, 1DBW) 
KinA 
KinB 
Spo0F B. subtilis 2 sensor histidine kinases, KinA and KinB autophosphorylate in response to nutrient 
deprivation or high cell density, and phosphorylate the first of two response regulators Spo0F. 
Spo0B, the second histidine kinase and phosphotransferase, receives a phosphate group from Spo0F 
and transfers it to the response regulator Spo0A (Min et al., 1993; Bijlsma and Groisman, 
2003)..(PDB Spo0F: 1FSP, 1PUX) (PDB Spo0F/Spo0B complex: 1F51, 1FTK) (PDB Spo0B: 
1IXM) 
Spo0B 
His30 
Spo0A 
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2.2 Methods 
 
2.2.1 Identification of all structural data on two-component histidine kinases  
 
It is believed that structure is more conserved than sequence (Illergard et al., 2009). The 
structural relationships within the previously identified HK groups were investigated using 
Discovery Studio (DS) software, to explore the relationship between structural motifs and the 
homology boxes found in HK sequences. 
Extracting 3D structures from the PDB database for use in protein BLAST searches resulted 
in thousands of hits. The E-value obtained in these results describes the number of hits one 
can expect to observe by chance when searching a database. Hence the lower the E-value, or 
the closer it is to zero, the more significant the match. The E-value can also be used as a 
convenient way to create a significance threshold for reporting results. Most HK have 
similarity in their conserved motifs (boxes) but overall similarity is low. The E-value could 
therefore not be used to differentiate between true HKs and other proteins. Consequently, the 
protein sequences were extracted by using the Enzyme Classification (EC) numbering 
(http://au.expasy.org/enzyme/) of HKs and this was supplemented by using the known Gene 
Ontology (GO, http://www.geneontology.org/) terms for sensor HKs. The CATH (Class, 
Architecture, Topology and Homologous superfamily, http://www.cathdb.info) and SCOP 
(Structural Classification of Proteins, http://scop.mrc-lmb.cam.ac.uk/scop/) databases were 
also used to identify close relatives in the HK family. The sequences found during these 
searches were then used as seed sequences for protein BLAST against the PDB database, to 
ensure all structures were searched exhaustively.  
 
2.2.2 Structural modelling of full length and truncated DevS 
 
The basic methodology used for homology modelling can be seen in Figure 2.1. It is a 
summary of the methods and results used in the in silico study of the Dev two-component 
system where the green boxes are exclusively for truncated DevS201, blue boxes are 
exclusively for full-length DevS and gray boxes include both. The construction and reason 
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for preparation of DevS201 will be explained in Chapter 3. It is linked to the successful in 
vitro expression and purification of the components of the Dev TCS. 
 
2.2.2.1 Identification of homologous proteins and multiple sequence alignment 
 
The two major requirements for building a homology model are, firstly, a known protein 
sequence of the model to be built, and secondly at least one high-resolution structure of a 
related protein that can act as a template. The first step here was to find homologues to both 
the full length and truncated DevS (DevS201) by using BLAST algorithm as provided by 
PDB website (Bernstein et al., 1977; Altschul et al., 1990). For modelling purposes, a 
multiple alignment of the homologous proteins was constructed. This was done to aid the 
identification of the conserved catalytic core present in familial HKs. Alignment was carried 
out with DS Align123, a multiple sequence alignment method based on the CLUSTALW 
program using the GONNET scoring matrix in DS (Thompson et al., 1994). To optimize the 
quality of the alignment, the gap opening and gap extension penalties were set to 15 and 0.31 
respectively. Furthermore, the alignment was manually adjusted to align the sequence motifs, 
as described by Grebe and Stock (1999). The delay divergent sequences property was set to 
20% and the secondary structure predictions were used. Since very little structural 
information regarding the DevS protein is available, some time was spent to gain as much 
sequence information as possible to assist in the process of modelling the protein structure of 
DevS. The sequence was subjected to various secondary structure prediction algorithms, 
listed in Table 2.2. Secondary structure prediction in DS was done by using the 
Discrimination of protein Secondary structure Class (DSC) method (King and Sternberg, 
1996).  
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Figure 2.1: Summary of the methods used in the in silico study of the Dev two-component system. Green boxes are 
exclusive for DevS201, blue boxes are exclusive for DevS and gray boxes include both. 
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Table 2.2: Secondary structure prediction algorithms utilized in this study. 
Program  Source 
GARNIER EMBOSS 
JNEPRED JNETHMM JNETALIGN JNPSSM  http://www.compbio.dundee.ac.uk 
JNETFREQ JPRED http://www.compbio.dundee.ac.uk 
PHD NNPREDICT HNNC SOPM SIMPA96 
PREDATOR DSC Sec.Cons GOR4 
http://npsa-pbil.ibcp.fr  
HMMSTER  http://www.bioinfo.rpi.edu 
PHD PSIPRED http:// cubic.bioc.columbia.edu 
 
2.2.2.2 Homology modelling  
 
For DevS, three distinct structural templates identified in the previous section were used in 
succession to span the complete length of the DevS protein, to provide a larger set of 
template-target residue pairs. These structures were 2W3E, 3GIG and 2VKS. Three separate 
templates for the DevS201 homology model were also identified, namely 1B3Q, 3GIG and 
2C2A. These templates were used and the models were built with DS MODELER using high 
refinement to generate 10 different conformer models (Sali and Blundell, 1993; Sali et al., 
1995).  
 
2.2.2.3 Energy minimization 
 
Models generated for DevS and DevS201 were typed by the CHARMM forcefield before 
being energy-minimized. Energy minimization was used to find a local energy minimum for 
each molecule in the model; a total lower energy state indicates a more stable model (Brooks 
et al., 1983). The Steepest Descent algorithm for minimization was applied, followed by the 
Conjugate Gradient method for faster convergence towards a local minimum (Fletcher, 
1969). The minimization was done for 2,000 steps with a root mean square (RMS) gradient 
of 0.1 Å using the Generalized Born implicit solvent model with a 14 Å non-bonded cut-off 
value, in addition to the DS’s spherical cut-off parameters for electrostatic bond definition 
(Dominy and Brooks, 1999).  
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2.2.2.4 Model assessment after minimization 
 
From these conformations, one representative model for each template was chosen that had a 
minimum number of residues in disallowed regions of a Ramachandran plot. The DOPE 
scores were also considered. To assess the quality of models after minimization, additional 
scoring functions were used and Ramachandran plots were obtained using DS MODELER. 
Protein structure and model assessment tools from the SWISSMODEL workspace were 
deployed, as well as the PROCHECK suite of programs (Laskowski et al., 1993; Arnold et 
al., 2006). PROCHECK assesses the stereochemical quality of a protein model and the output 
is displayed via a Ramachandran plot. For full length DevS, loop modelling refinement by 
DS MODELER was used to define one or more residues in the model that have no 
corresponding template residues, consequently found in the disallowed regions of the 
Ramachandran plots (Fiser et al., 2000).  
 
2.2.3 Protein-protein interactions 
 
Once suitable structures representing DevS and DevS201 were built, these structures were 
used to model and study protein-protein interactions between DevS and DevR. Two methods 
were used: homology docking and DS ZDOCK. 
 
2.2.3.1 Protein homology docking 
 
To produce a starting point for predicting protein-protein interactions, homology docking was 
used. This entailed modelling DevS and DevR onto the crystal structures of two other 
component histidine kinases. Two crystal structures were used where the response regulator 
and the HK are present in association. Since sequence homology between DevS and the 
template kinases was low, the structural similarities and topologies were used to superimpose 
the structures. The structural similarities of the template structures were quantified by 
secondary structure topologies present in the crystal structures. The topologies for DevS were 
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based on the homology models as well secondary structure predictions based on its sequence, 
using the DS DSC method (King and Sternberg, 1996). 
Minimization with DS was used to arrive at a more accurate model of association. Three 
different minimization methods were used during this minimization step and the energy 
change was monitored closely. First, an Adopted Basis-set Newton-Raphson (ABNR) was 
used for 2,000 steps, (RMS gradient set to 0.1 kcal⁄mol/Å), followed by Steepest Decent for 
4,000 steps, (RMS gradient 0.01 kcal/mol/Å), followed by Conjugated Gradient for 6,000 
steps, (RMS gradient 0.001 kcal/mol/Å) and finally Steepest Decent 10,000 steps, (RMS 
gradient 0.001 kcal/mol/Å). The model with the lowest energy change over time was selected 
as the most accurate and the interaction sites were analyzed and compared to those found in 
the DS ZDOCK results.  
 
2.2.3.2 Protein-protein docking using DS ZDOCK 
 
DevS201 and DevR were typed by the CHARMM forcefield before docking commenced 
(Brooks et al., 1983). DS ZDOCK was run on default values with the distance interaction cut-
off set to 10 Å and the angular step size at 6. The docked poses with a RMSD of less than 
10 Å overall were clustered together into not more than 100 clusters (Comeau et al., 2004). 
DS ZRANK was used to rank the top 2,000 poses for further analysis (Pierce and Weng, 
2007). The clusters were colour-coded based on their DS ZRANK score, red being indicative 
of a high score and blue indicative of a low score. All clusters with low scores were removed. 
Consequently, DS RDOCK was used for refinement of the top poses; using CHARMM with 
a dielectric constant of 4, the molecules were typed with CHARMM polar H to increase the 
speed of the scoring function.  
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2.3 Results 
 
In the (PDB) there are currently 68,701 protein structures available, 89 of which are classified 
as HKs based on their EC number. That number drops to 60 when structures with more than 
90% homology are removed, eliminating molecules that were crystallized more than once. 
SWISSPROT, a curated protein sequence database contains 47,734 HK sequences. When all 
redundancy was removed, a total of 5,573 unique HK sequences were available. These 
statistics emphasize the significant gap between sequence and structural data available for the 
HKs.  
 
2.3.1 Identification of all structural data on two-component histidine kinases  
 
For each PDB entry, the protein structures were compared with their respective protein 
sequences from the NCBI database and it was concluded that most of the structures were 
partial structures. Only 2 full length HK structures were available, CheA (T. maritima, 
1UOS) and PhoR (T. maritima, 2C2A). The structural data of the kinases found in the PDB 
database was mined to see if there was a relationship between the structures and the functions 
of these sensor kinases. Table 2.3 shows the different classes that the histidine kinase sensors 
could be divided into, based on structure.  
2.3.2 Classification of DevS 
 
Kim and Forst (2001), took a phylogenetic approach to analyse the HK family in bacteria and 
archae. The HK groups were defined based on a phylogenetic analysis of the protein 
sequences. They concluded that all the HKs could be grouped in 5 different groups. These 
five common transmitter domains were used to BLAST against the DevS ORF to try and 
classify DevS into one of the five defined groups. It was found that DevS belongs to Class 3, 
along with only three other known (E.coli) HKs: NarX, NarQ and UhpE. When using the 
Grebe and Stock (1999), scheme it was found that DevS belongs to Group 7 (HPK7), which 
contains DegS and NarQ. The H-box in this group is distinguished by the presence of a 
negatively charged group two residues upstream from the conserved histidine and a positively 
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charged residue, usually an arginine, eight residues upstream. This places these residues 
adjacent to one another on one face of the presumed H-box -helix. In addition, the phospho-
accepting histidine is followed by an aspartate residue in all cases. The proline and 
phenylalanine that tend to be conserved in most kinase H-boxes are generally missing in 
HPK7 kinases. The N-box is also distinct: the second asparagine is conserved but in place of 
the first asparagine there is a glutamate. In addition, the F-box is absent and the distance 
between the D- and the G-boxes is reduced. This structural classification of DevS was needed 
to identify its closest relatives for homology modelling.  
 
Table 2.3:  The histidine kinase sensors can be divided into different classes based on structure 
Class Sensor  
Kinase 
Function PDB accession 
number 
1 DctB 
DcuS 
C4 dicarboxylate sensor 
citrate sensor 
3BY9 
3BY8 
2 LuxQ 
CitA 
cell density sensor 
citrate sensor 
2HJE 
2V9A 
3 AppS 
PhoQ 
function unknown  
related to virulence 
3CWF 
1YAX 
4 CheA flagellar motion 1UOS 
5 EnvZ 
NtrB 
osmoregulation 
nitrogen sensor 
1BXD 
1R62 
6 ArcB 
YojN 
aerobic sensor 
involved with polysaccharide synthesis 
1AOB 
1SR2 
7 CheA 
PhoR 
PrrB 
flagellar motion 
redox stated and Mg2+ 
M.tb virulence 
2C2A 
1B3Q 
1YSR 
8 FixL 
NifL 
KinA 
PprS 
oxygen sensor 
cellular redox states 
sporulation 
function unknown  
1DO6, 1DRM 
2GJ3 
2VLG 
1MZU 
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2.3.3 Structural modelling of DevS and DevS201 
 
2.3.3.1 Identification of homologous proteins and multiple sequence alignment  
 
The classification scheme provided by SCOP and ASTRAL may be used as a guideline for 
structure selection (Brenner et al., 2000; Lo Conte et al., 2000). This provided some useful 
insight where the homology modelling was concerned. For DevS201 (truncated version of 
DevS), three structurally different templates were found during the BLAST search, as seen in 
Figure 2.2(A). DevS201 showed 49.3, 39.0 and 39.4% sequence homology to 3GIG (B. 
subtilis DesK), 1B3Q (T. maritima CheA) and 2C2A (T. maritime PhoQ), respectively. Three 
separate models were built based on the three templates and the predicted protein structures 
were critically assessed to determine the more accurate model. No template could be found 
that spanned the complete length of the DevS sequence, so three different sequences had to 
be used as templates for the various parts of the full length sequence, as can be seen in Figure 
2.2(B). From position 0 to 148, DevS shows 83.8% homology to 2W3E (M. tb DevS 
fragment), 15.7% homology to 2VKS (M. smegmatis DevS fragment) in position 173 to 322, 
and the C-terminal kinase core from position 305 to 525 has 19.4% homology to 3GIG. 
These three template structures were used simultaneously to build a model of full length 
DevS.  
 
2.3.3.2 Homology modelling and model assessment  
 
DS Modeller produced 10 different conformer models for each template used for DevS and 
DevS201. Energy minimization was used to find a local energy minimum for each molecule 
in the model; a total lower energy state indicates a more stable model. Homology model 
quality assessment is usually performed using two methods: statistical potentials or physics-
based energy calculations. Both methods produce an estimate of the energy or an energy-like 
value that can be used to determine the structural accuracy of the model. Various scoring 
functions were used to identify the best model for DevS and DevS201. DS uses Probability 
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Figure 2.2: Sequence alignment between A) DevS201 and B) DevS and their closest homologues. Residue colours: 
Black is high sequence similarity, blue is strong, yellow is weak and red indicates no sequence similarity, respectively. 
Background colours indicate the predicted secondary structure, helices are red, sheets in blue and coils are green. The 
residues without a coloured background form parts of loops or there are mismatches in the prediction. The red line on the 
ruler in (B) indicated where the DevS201 protein will start, i.e. where DevS was truncated to form DevS201. 
 
Density Functions (PDF) to calculate pseudo-energy terms and stereochemical pseudo-energy 
terms. DOPE is a knowledge-based scoring function that is often termed statistical potential 
scoring function. The DOPE scoring function is an atomic based statistical potential measures 
the relative stability of a conformation. The verification score for each amino acid residue is 
based on the secondary structure and indicates whether a residue is in the desired 3D 
environment. QMEAN is a composite scoring function consisting of 5 terms: torsion angle 
energy, distance-dependent pairwise residue-level potential used to assess long-range 
interactions, solvation energy, and agreement between predicted and observed secondary 
structure and agreement between predicted and observed solvent accessibility. Results of the 
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scoring functions were used to select the best conformers. The results for the best conformers 
for DevS201 are outlined in Table 2.4. Ramachandran plots were also used to select the best 
conformers (Figure 2.3), as well as monitoring the conformational changes due to energy 
minimization. Ramachandran plots were used to compare the residues in favourable, as well 
as disallowed, regions of each model. 
Table 2.4: Results of the best conformers of the various scoring functions used during the model building of 
DevS201 
 
 
Based on the Ramachandran plots (Figure 2.3) and results from scoring functions (Table 2.4), 
the best DevS201 conformer from each template was chosen and can be seen in Figure 2.4 
The 3GIG model was chosen as the best model for DevS201 based on the energy values 
predicted by the scoring functions mentioned in Table 2.4. 
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Figure 2.3: Ramachandran plots for the DevS201 models based on three templates and the full length DevS. The top row is the Ramachandran plots as built by DS MODELER using 
1B3Q, 2C2A, 3GIG and the full length DevS. The bottom row indicates the Ramachandran plots after minimization runs. The Ramachandran plots were produced by PROCHECK. Most 
sterically favoured regions (red), additional allowed regions (dark yellow), generously allowed regions (light yellow) and disallowed regions (white). The x-axis shows the variance in the Phi 
angle and the y-axis the Psi angle. After energy minimization the number of amino acids in the disallowed regions decreased drastically for all DevS201 models. Comparison of the eight amino 
acids present in the disallowed regions of full length DevS before with the six amino acids present after energy minimization, indicated that the loops needs more optimization. 
Stellenbosch University http://scholar.sun.ac.za
32 
 
 
 
Figure 2.4: DevS201 models build by DS MODELER based on three different templates. The model on the left was 
built based on 1B3Q (blue), middle based on 2C2A (pink) and on the right based on 3GIG (green). The active residues are 
not shown in the models since the calculations do not impinge on them. 
 
For DevS there was only a single model and the structure in Figure 2.5 (A) was produced. 
The comparison of the amino acids present in the disallowed regions of full length DevS 
before and after energy minimization (Figure 2.3), indicated that the loops needed more 
optimization. Loops can be defined as those pieces of protein where homology was low or no 
sequence was present. For DevS, there were a few stretches of protein that had no homology 
or very low homology, so loop refinement from DS MODELER was done. In Figure 2.5 (A), 
DevS is shown with the four loops identified as Asp121-Leu130, Arg142-Pro170, Tyr382-
Ser388 and Phe405-Pro419. Figure 2.5(B) displays the loops after refinement in purple. Each 
LOOP REFINEMENT run produced ten different conformations of each loop. The best 
models were chosen based on the DOPE scores available for the loops. The only exception 
was the longest loop (Arg142-Pro170), where the DOPE score for the original conformation 
matched the predicted DOPE score of the refined conformation. No clear conclusion on the 
more correct orientation could therefore be reached. Figure 2.5(C-F) shows the original loops 
in green and the modelled loops in purple. When the DevS201 model and the DevS model, 
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with loop refinement, was superimposed a RMSD of 7.4 Å was observed. Figure 2.6 shows 
the similarities in the two structures. 
 
 
Figure 2.5: DevS full length model with loop modelling. (A) DevS model as produced by DS MODELER with four loops 
identified: Asp121-Leu130, Arg142-Pro170, Tyr382-Ser388 and Phe405-Pro419 (all showed in green). (B) The loops after 
loop refinement are shown in purple. (C) Closer look at loop Asp121-Leu130. (D) Loop Arg142-Pro170. (E) Loop Tyr382-
Ser388. (F) Loop Phe405-Pro419. 
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Figure 2.6: The DevS201 and DevS models superimposed. DevS201 model (in green) and the DevS (in dark pink) model 
superimposed to show similarities. The DevS transmembrane domain is not depicted as secondary structures. 
 
2.3.4 Protein-protein interactions 
 
Due to the limited nature of the structural data available for DevS and DevR, attempting in 
silico protein-protein docking without any prior knowledge would be impossible. 
Consequently, protein-protein docking was done based on structure similarity of known 
crystallized two-component kinases systems. Very little structural or biochemical information 
was available that could guide the docking. The ability of scoring functions and minimization 
techniques was used extensively to guide the study to reach a near-native structure. 
 
2.3.4.1 Protein homology docking 
 
During the similarity search, two reference structures were found in the PDB database of 
HKs that were crystallized while interacting with their corresponding response regulators. 
3A0R contains T. maritima histidine kinase (HK) ThkA in complex with response regulator 
(RR) TrrA, while 3DGE contains T. maritima HK853 in complex with RR468. Table 2.5 
contains the sequence similarity data between these crystal structures and the DevS and DevR 
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model structures. HK853 shows a high homology towards DevS, but it was only crystallized 
after the DevS201 models were built. A comparison between the DevS201 model and the 
HK853 showed a RMSD of 12.85 Å, which indicates the DevS201 is a good HK 
representative model.  
 
Table 2.5 Information on sequence similarity between DevS and DevR and the respective templates 
 
PDB 
accession 
number 
Histidine 
kinase (amino 
acid length) 
Percentage 
similarity to 
DevS 
Response 
regulator  
(amino acid 
length) 
Percentage 
similarity to 
DevR 
Organism Literature 
Reference 
3AOR ThkA (343) 21.7% TrrA (115) 47.5% T. maritima Yamada et al., 
2006 
1DGE HK853 (237) 36.3% RR468 (122) 46.0% T. maritima Casino et al., 2009 
 
The protein-protein interactions between DevS and DevR were modelled, based on these 
known structures of interacting two-component systems. The topology comparisons for the 
HKs are shown in Figure 2.7. A  motif was found in the DevS HK models, as in the 
ThkA and HK853 crystal structures. 
 
Figure 2.7: Topology comparisons between DevS201 and other known histidine kinases. Topologies for DevS201 based 
on template 2C2A (a), template 3GIG (b), ThkA from T. maritima (c) and HK853 from T. maritima (d). The red tube 
represents an -helix, the blue arrow represents a -sheet and the loops are coloured green. The black blocks indicate the 
 motif. 
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Optimal similarity between DevS and the template kinase was found when the topologies of 
the catalytic cores were compared. The catalytic core is more conserved than the sensor 
domain. Only the DevS201 models, containing the catalytic core, were therefore used to 
investigate protein-protein interactions. The assumption that the DevS201 can be used to 
model comprehensive protein-protein interactions was further investigated in Chapter 3. 
Wisedchaisri et al. (2008) reported crystal structures of full-length unphosphorylated DevR at 
a 2.2 Å resolution. This structure was used in this investigation. When analyzing the 
topologies for the response regulators (Figure 2.8), an ()5 repetitive motif was found. The 
DevR structure does not have the 9-sheet; however a loop was predicted for the 
corresponding amino acids. Benda et al. (2004) defined this distinctive fold of response 
regulators, where the 5 sheets are sandwiched between the 2 and 3 helices (Figure 2.8). 
 
 
Figure 2.8: Topology comparisons between DevR and other known response regulators. The topologies for TrrA from 
T. maritima and RR468 from T. maritima were identical and depicted in (a). The topology for DevR is shown in (b). The red 
circle represents an  helix, the blue square represents a  sheet and the loops are coloured green. The ()5 motif is 
observed and described for response regulators by Benda et al. (2004). 
These topologies were used to superimpose the DevR and DevS structures on the 3A0R and 
3GDE reference structures (Figure 2.9). The interactions between HK ThkA and its response 
regulator TrrA are outlined in Figure 2.9(A). Figure 2.9(B) shows the DevS201 superimposed 
on ThkA, Figure 2.9(C) shows DevR superimposed on TrrA and Figure 2.9(D) shows the 
DevS201 and DevR interaction. TCSs are known for their His-Asp phosphotransfer; the close 
proximity of His398 and Asp54 makes the model more plausible.  
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Figure 2.9: Homology docking based on the crystal structure of histidine kinase. (A) The histidine kinase ThkA (grey) in complex with the response regulator TrrA (purple) of T. maritima, 
the His547 is indicated in yellow and the Asp52 is indicated in red. (B) The histidine kinase DevS201 (blue) was superimposed onto ThkA, and His395 is indicated in yellow. (C) The response 
regulator DevR (green) was superimposed and the Asp54 is indicated in red. (D) The final binding conformation between DevR and DevS201, with the his-asp residues in close proximity. 
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In order to further refine the association between the DevS201 and the DevR molecule, a 
series of minimizations was done on the molecules individually and then as a dimer. The 
resulting energy values were: DevS201 -3972.17 kcal per mol, DevR -12153.77 kcal/mol and 
the dimer -11352.52 kcal/mol. The energy of the associated molecules was much lower than 
that of the separate molecules.  
2.3.4.2 Protein-protein docking with DS ZDOCK 
 
The aim of protein-protein docking is to assemble separate protein components into a protein-
protein complex. The protein receptor (DevS) and a protein ligand (DevR) were docked to 
form an optimized conformation, such that the free energy of the overall system is 
minimized. A pose is defined as the relative orientation between the receptor protein and 
ligand protein. DS ZDOCK is a rigid body docking program that uses Fast Fourier 
Transformation which produced 54,000 docked poses meeting the criteria set by the distance 
cut-off filter. These molecules were clustered into 100 clusters, the largest of which contained 
233 poses. The clustering analysis provided by the ZDOCK protocol is based on the RMSD 
matrix. Clustering is predominantly utilized to reduce the number of hits coming from 
ZDOCK, since the capacity to analyze each pose is far more limited than the capacity to 
generate hits. The purpose of scoring functions during protein-protein docking is to select the 
most favourable ranking solution that would give an insight into the affinity of the complex. 
For that reason, ZDOCK, RDOCK and ZRANK were used to distinguish near-native 
structures. Subsequently, all those molecules with positive values were removed, decreasing 
the dataset to 2,000 possible docking hits (also referred to as poses). Analysis based on the 
DS ZDOCK score, DS ZRANK score, overall rank and cluster size was then done and the 
results visualized using 3D plots (Figure 2.10). The criteria for a pose to be carried over to 
the next round of optimization were a high DS ZDOCK score, low DS ZRANK score, low 
overall rank and preferably part of a big cluster.  
Figure 2.10(A) shows the 2,000 poses used for the analysis and Figure 2.10(B) shows the 
remaining 1,000 poses to be submitted for further analysis and optimization. DS RDOCK 
was used for the refinement of the top 30 docked complexes using a CHARMM-based 
procedure for refinement and scoring, identifying near-native structures (Brooks et al., 1983).  
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Figure 2.10: A 3D plot of ZRANK, ZDOCK and RDOCK scores. The dots represent cluster centres where DevR can 
potentially bind to DevS. The ZRANK and ZDOCK scores of the top 2,000 poses are shown in (A), with the high energy 
poses were removed in (B), and the final 16 poses in (C) and (D). For (A), (B) and (C), the colours of the dots represent the 
rank that pose has in relation to the others. In (D), the dots are coloured based on their RDOCK score. 
 
Those poses with positive DS RDOCK values were removed from the dataset, as positive 
values can be indicative of clashes that could not be removed via minimizations.  The 
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remaining 16 poses and their scores were visualized in Figure 2.10(C) and (D). The 16 best 
scoring docked poses were further analysed for their RMSD between different docked poses. 
The best poses from the docking results are shown in Figure 2.11. Only experimental data 
would be able to give a clear indication of which of the four models are correct. 
 
 
Figure 2.11: Final poses produced by ZDOCK for DevR binding to DevS201. The light blue molecule is DevS201. The 
different poses indicate the different ways in which DevR can bind to DevS. (A) Pose 1644 (lime green). (B) Pose 145 
(orange). (C) Pose 324 (pink). (D) Pose 1508 (purple). In all of these poses, the His395 indicated in red is in close proximity 
to the Asp54 indicated in yellow. 
 
The kinase core bears the phospho-accepting His residue within conserved sequence 
fingerprints called homology boxes. The H-box for DevS is RDLHDHVTQ, with His395 
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being the conserved histidine. This kinase core is a helical domain with structural similarity 
within the histidine kinase family, this suggested that the helical bundles facilitate histidine 
phosphorylation as well as dimerization. The histidine domain of DevS spans 67 residues 
starting at Asp386 to Gly452. The dimer interface is located in the helical-hairpin domains 
with the helices such that the cytosolic domains are adjacent, and in position to originate from 
the membrane.  The helix 1 includes the His395 phosphorylation site and helix 2 makes 
helix–bundle contacts with helices of DevR.  
 
2.4 Discussion:  
 
Literature demonstrates that highly conserved regions are present in kinase proteins. HKs 
have these conserved domains in the regions where the phosphorylation takes place and at the 
ATP binding site. The kinase domain (catalytic core) consists of four conserved sequence 
motifs, namely the H, N, G1 and G2 boxes, and a more variable F-box. The HK superfamily 
has been classified according to various criteria. A protein family is defined as a group of 
proteins that share structure, sequence and functional similarity, suggesting they are derived 
from a common ancestral protein (Scheef and Bourne, 2005). The aim here was to place the 
HK catalytic core sequence motifs into a structural context, and create a model of the 
interactions between DevS and DevR.  This was achieved in the manner described below.  
BLAST, EC numbering, GO terms, CATH and SCOP databases were first used to find 
detailed structural information for the HK protein family. HKs are known to be insoluble 
when expressed in vitro as they are usually found as membrane-bound proteins (Saini et al., 
2004a). Consequently, scientists tend to truncate the kinases and express, purify and 
crystallize only the domain they are interested in. As a result, it was found that there is a 
general lack of detailed structural information for full length HKs. Only 2 full length 
structures were available in the PDB database, CheA (T.maritima, 1UOS) and PhoR 
(T.maritima, 2C2A).  
All the HK catalytic core structures clustered into 8 different classes. The CheA full length 
molecule was classified in its own class (class number 4). Structures with the same proven 
function, as well as structures from the same organism but different lengths were classified in 
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different classes, for example PhoQ classified into both class 3 and 5. The conclusion drawn 
from this data was that the partial structures do not contain enough information for 
comparative analysis between structure and function.   
Homology modelling has five major weaknesses that should be kept in mind when structures 
are modelled: the correctness of the templates used, the alignment between the templates and 
the sequence to be modelled, regions without templates, backbone distortion and side chain 
packing. Each of the weaknesses was addressed during the molecular modelling of DevS and 
some shortfalls noted.  
In order to ensure that the correct templates were chosen it was important to know where 
DevS belongs based on structural analysis. Template proteins require close homology in 
order for DevS to be modelled reliably. The DevS DNA sequence was compared to the 
known HK classes, and NarX, NarQ, UhpE and DegS were identified as being homologous 
to DevS. However, the aim was to produce a reasonable approximation of the DevS protein 
structure using the known structure of proteins related to DevS by homology. DevS was 
modelled using templates from DevS (M. smegmatis) and DesK (B. subtilis), while DevS201 
was modelled using templates from DesK (B. subtilis), CheA (T. maritima) and PhoQ 
(T. maritima).  
The accuracy of these models is dependent on the sequence identity between target and 
template, as well as the correct alignment. When the models were designed, special care was 
taken to realign DevS201 with its templates based on the homology boxes found in HKs. The 
secondary structures for those motifs were identical and this provided more information and 
therefore increased the quality of the model.  
When choosing templates for the full-length DevS model, we were faced with a problem that 
there were portions of sequence that did not have a template or where the homology was so 
low that no secondary structure could be inferred. In these cases we relied on loop-modelling 
and loop refinement to arrive at the best conformation for those portions of sequences.  
Energy minimization steps were used to improve the accuracy of the models. Energy 
minimization was used to find a local energy minimum for each molecule in the model: a 
total lower energy state indicating a more stable model (Brooks et al., 1983).  
Homology model quality assessment is usually performed using two methods: statistical 
potentials or physics-based energy calculations. Both methods produce an estimate of the 
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energy or an energy-like value that may be used to determine the structural accuracy of the 
model. Various scoring functions were used to identify the best model for DevS.  
DS uses Probability Density Functions (PDF) to calculate pseudo-energy terms and 
stereochemical pseudo-energy terms (Sali and Blundell, 1993). The PDF energy is the sum of 
energies of the stereochemical pseudo-energy terms which consist of valence bonds, valence 
angles and torsion angles, improper torsion angles, and soft-sphere repulsion (Sali and 
Blundell, 1993). Higher energy indicates a larger restraint violation in the model. These 
functions were used address backbone distortion and side chain packing in the DevS and 
DevS201 models to ensure that no torsion or spatial rules were violated during the building of 
the models. 
The Discrete Optimized Protein Energy (DOPE) scores of each model were also assessed. A 
lower DOPE score statistically indicates a better model. DOPE is a knowledge-based scoring 
function that is often termed statistical potential scoring function. The energy values 
produced is based on the atomic distance-dependent statistical potential from known protein 
structures, based on probability theory (Shen and Sali, 2006). 
The verification score determined for each amino acid residue is based on the secondary 
structure and indicates whether a residue is in the desired 3D environment. The higher the 
score, the greater the probability that the structure is more likely to be correct. DFire is a 
scoring function that calculates the residue-specific all-atom, distance-dependent potential of 
mean force by using a physical state of uniformly distributed points in finite spheres as an 
indication of the quality of the model (Zhou and Zhou, 2002). QMEAN is a composite 
scoring function consisting of 5 terms: torsion angle energy, distance-dependent pairwise 
residue-level potential used to assess long-range interactions, solvation energy, and 
agreement between predicted and observed secondary structure and agreement between 
predicted and observed solvent accessibility (Benkert et al., 2008).  
Protein-protein docking is the computational modelling of the three dimensional structure of 
the interactions formed between two proteins as it would occur in a living organism. This 
produces probable candidate structures, which must be ranked using methods such as scoring 
functions to identify structures that are most likely to occur in nature. Probable candidate 
structures of DevS-DevR complex were modelled. Homology docking based on structure 
similarity of known crystallized two-component kinases systems was performed to reach a 
near-native structure for the binding of DevS201 to DevR. The T. maritima ThkA/TrrA and 
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HK853/RR468 TCSs were used as templates to model the 3D structure of the DevS-DevR 
complex. During the DevR and DevS dimerization analysis it was observed that the His395 
and Asp54 residues were in different positions.  
Marina et al., 2005 observed that there was a separation between ATP and the 
phosphoacceptor histidine in this structure of HK853-CD, suggest that the cytoplasmic 
portions of HK sensor must access multiple conformational states, some of which are critical 
for catalytic action. In a similar manner it would seem possible that the conformational state 
for phosphotransfer is different from the conformational state of the monomer. Since the 
DevR and DevS structures were first modelled using monomer structures as basis it could be 
possible that the conformation used in this homology docking is not the true form of both the 
proteins during dimerization. Support for this notion was found by Wisedchaisri et al., 2008 
that reported that DevR undergoes conformational changes when phosphorylation occurs via 
a helix rearrangement mechanism. The full-length DevR structure indicated that in the 
inactive conformation, domain interaction buries Asp54 residues from accessibility to solvent 
(Wisedchaisri et al., 2008). Consequently the spatial orientation of asp residue observed in 
the DevR model used in the homology docking study might also be different during 
dimerization. This highlights one of the biggest short fall of homology modelling, the 
conformational changes cannot predicted accurately.  
Molecular mechanics and molecular dynamics could be used to simulate the physical 
movement of atoms and molecules. Unfortunately both molecular mechanics and molecular 
dynamics for a dimer complex are very computationally expensive. In order to overcome the 
computational as well the size constraints a method like normal mode analysis could have 
been used to identify some of the potential conformational changes. 
The ZDOCK docking algorithm was used to determine the quaternary structure of the 
complexes by allowing the relative orientations of the interacting proteins being modelled to 
vary, while holding the structure of each of the separate proteins fixed.  
Scoring functions can be put to a number of good uses. Classically scoring functions are used 
to determine the lowest energy conformation of a protein, assuming the near-native structure 
(Anfinsen, 1973). Where protein-protein docking is concerned, the calculations of the energy 
minimization that goes together with these scoring functions become too extensive and too 
complex to explore exhaustively. Scoring functions like ZRANK and RDOCK that give good 
approximations of the minimum energy were used to ensure that undesirable (high energy) 
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conformations were removed from the dataset, rather than to assume the lowest energy is the 
native form (Lorenzen and Zhang, 2007; Pierce and Weng, 2007). DS ZRANK is an energy-
based scoring function that predicts the strength of intermolecular interactions between two 
proteins. DS ZRANK uses three energy terms based on van der Waals interactions, 
electrostatic interactions and solvation energy to score all the poses. A positive value is an 
indication of very little or no interaction between the proteins or it could indicate residue 
clashes or other improper steric torsions.  
After these steps, more than one conformation for the DevS-DevR complex with similar 
docked energies was observed. The decision on which conformation was the more correct 
form can only be estimated by comparison to known TCS systems. Alternatively, 
crystallization of this complex would be the ultimate proof for these models. A model of the 
ATP binding moiety is not available. None of the template models have a co-crystallized 
ATP that could be superimposed into the DevS models. Small ligand docking can be pursued 
in the future to try and co-ordinate the ATP to the amino acids it is known to bind. 
Before any model can be deemed correct, a series of experimental data must be collected to 
ensure that the catalytic site, the binding site as well the other binding interactions can be 
explained by the model. Consequently, functional expression and activity testing of DevS and 
DevR were pursued, and are described in the following chapters.  
The first priority was to determine if the binding affinity between DevR was the same for 
DevS as for DevS201; to validate our assumption to do the majority of our modelling based 
on DevS201. If this proves to be correct, the next step would be to do site-directed 
mutagenesis to determine which amino acids of DevS play a role in the binding between 
DevS and DevR.  
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Chapter 3 Expression, purification and 
activity studies of the Dev two-
component system 
 
 
3.1 Introduction 
 
Due to the complexity of the Dev TCS, the techniques to assess this system were put in place 
using the Bacillus subtilis SpoII TCS system as a model. A functional kinase assay was 
needed to measure phosphate transfer, so the SpoII TCS was used as a model system to test 
the methods by which the radioactively labelled 32P-ATP is used to track the phosphorylation. 
Mutation studies were done on SpoIIAB to assess the sensitivity of the assays for future 
usage in DevR mutation phosphorylation assays. Consequently, the SpoIIAA and SpoIIAB 
phosphorylation system was used to ensure the reliability and sensitivity of the kinase assay.  
 
3.1.1 B. subtilis SpoIIAA and SpoIIAB system 
 
B. subtilis uses the transcription factor F to control transcription of sporulation-specific 
proteins (Partridge et al., 1991). F is bound in an inactive form to the anti- factor SpoIIAB, 
which prevents transcription of relevant proteins. In the presence of ATP, SpoIIAB can either 
bind to and inhibit F, or act as a specific protein kinase to phosphorylate SpoIIAA (Duncan 
and Losick, 1993; Min et al., 1993; Diederich et al., 1994). SpoIIE is a specific protein 
phosphatase whose substrate is the phosphorylated form of SpoIIAA (Duncan et al., 1995). 
Before sporulation, SpoIIAA is present largely or exclusively in the phosphorylated form, 
and consequently does not interact with SpoIIAB, leaving SpoIIAB unbound and free to 
inhibit F (Diederich et al., 1994; Arigoni et al., 1996). During sporulation, SpoIIE becomes 
active and dephosphorylates SpoIIAA. Unphosphorylated SpoIIAA can now bind to 
SpoIIAB. Once the SpoIIAB becomes involved in the phosphorylation of the newly-released 
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SpoIIAA, it releases F. The phosphorylation involves the transfer of the phosphate to Ser58 
of SpoIIAA (Najafi et al., 1995). It was interesting to note a histidine close to the ATP 
binding site of SpoIIAB (Campbell et al., 2002). Although this histidine is not mentioned in 
the catalytic mechanism in literature, this histidine could be relevant (Diederich et al., 1994). 
The mutation of this His54 residue to an alanine may elucidate its potential role in the 
phosphorylation of SpoIIAB. Phe110 is within the ATP-binding site, and makes hydrophobic 
contacts with the face of the adenine ring (Campbell et al., 2002). Mutants at this position 
will decrease ATP binding activities, leading to the proposal that this residue functions in 
transition-state stabilization during the phosphorylation reaction. 
 
3.1.2 Protein expression and purification 
 
The quest for soluble functional protein has been an essential component of protein binding 
studies. One of the main complications during the expression of recombinant proteins in E. 
coli is the formation of inclusion bodies - aggregates of insoluble misfolded proteins (Baney 
and Mujacic, 2004). Inclusion body formation can be attributed to various factors, including 
the usage of strong promoters and high inducer concentrations (Tsumoto et al., 2003). The 
increase of foreign protein in the host’s cellular environment can also escalate the rate of 
protein misfolding and aggregation. Unfortunately, bacteria lack the ability to support most 
post-translational modifications such as intra- or intermolecular disulphide bond formation 
and this can also lead to aggregation of proteins (Baney and Mujacic, 2004). There is a clear 
distinction between precipitated proteins and inclusion bodies. The former are proteins in 
their native form that randomly precipitate due to a reduction of solubility of the polypeptide 
chain, for example during salting out procedures. Inclusion bodies are believed to be the 
consequence of interactions between hydrophobic residues in unfolded or partially folded 
proteins that become exposed at the protein surface (Clark, 1998). The most frequently used 
scheme to recover biologically active proteins from inclusion bodies involves three steps: 
isolation of the inclusion bodies, solubilisation of the inclusion bodies and refolding of 
solubilised proteins. Although inclusion bodies can be a dead end to a soluble expression 
study, it does have the advantage that their isolation from the cell is very convenient as a first 
purification step (Rogl et al., 1998). Following either mechanical or chemical cell lysis, 
inclusion bodies can be collected by centrifugation. Washing the pellet with a detergent such 
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as Triton X100 or sodium deoxycholate should remove soluble proteins that might be stuck to 
the hydrophobic inclusion bodies (Clark, 1998). These proteins can hinder the refolding step. 
Otherwise, a sucrose gradient centrifugation step can be added to remove contaminating cell 
debris (Clark, 1998).  Various solubilising conditions should be taken into consideration 
when proteins are refolded. Commonly used solubilisation agents are urea, guanidine-HCl 
and strong ionic detergents such as N-lauroylsarcosine and acids like formic acid (Tsumoto et 
al., 2003). Occasionally, chelating agents can be included in the solubilisation buffer to 
prevent oxidation reactions that may occur in the presence of metals. Temperature gradients 
between 30°C and 37°C are used to facilitate the process. The structure after solubilisation is 
dependent on the denaturant used: urea and guanidine-HCl produce flexible disordered 
structures, whereas detergents produce a much more ordered structure. However, with the 
controlled treatment of urea and guanidine-HCl, it is possible to get more efficient refolding 
because these chemicals undergo concentration-dependent binding to proteins (Clark, 1998; 
Tsumoto et al., 2003). The various approaches used to refold the proteins include dilution, 
dialysis and solid phase methods. The main aim of all these methods is to unfold the protein 
by using a detergent or alternative chaotropic chemical and then to stepwise remove the 
denaturing agent, allowing the protein to refold into its native conformation. In literature, it 
was shown that there is no universal refolding buffer or native structure recovery procedure. 
The refolding buffer usually refers to the buffer used to remove the denaturing agent and 
consequently is the buffer in which the protein is stable and soluble (Singh and Panda, 2005). 
The composition of the refolding buffer is protein-specific and depends on various factors 
such as ionic strength, pH, specific metal requirements and reducing agent (Vincentelli et al., 
2004; Ventura, 2005). Nickel-chelating chromatography can be used as an example of solid 
phase refolding. This has the advantage of preventing further aggregation since the proteins 
are immobilized with their hydrophilic faces exposed, and are not free to associate with other 
proteins. This method combines the refolding step with a purification protocol (Rogl et al., 
1998).  
 
3.1.3 Factors influencing DevS solubility 
 
It has been shown that the cytoplasmic domain of DevS is capable of autophosphorylation 
and phosphorylation of DevR (Saini et al., 2002). The N-terminal sensor domain is composed 
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of three transmembrane regions, and is also referred to as the membrane anchor domain. This 
hydrophobic part of the protein will influence protein folding and protein solubility. 
Erroneous hydrophobic interactions can cause misfolding and aggregation in inclusion bodies 
(Baney and Mujacic, 2004). For histidine kinase functionality, the only catalytic kinase core 
is needed, therefore by removing the hydrophobic part of the protein upstream from the 
His395 residue, the cytosolic region containing all the functional boxes will still be present. 
The location of the boxes as well as the phosphorylated His395 residue can be seen in Figure 
3.1. Removing this hydrophobic domain should lead to better folding and increase solubility 
(Saini et al., 2002). 
 
 
Figure 3.1: Significant features of DevS. The three predicted N-terminal transmembrane regions (TM1, TM2 and TM3) of 
DevS are indicated by the green arrows, with the corresponding residues indicated underneath. The His395 that forms part of 
the H box and which is autophosphorylated is indicated in red. The conserved N, D/G1 and G2 boxes are shown in light 
blue. The 201 amino acid cytosolic fragment of the C-terminal region of DevS is referred to as DevS201. 
 
3.2 Materials and methods 
 
3.2.1 SpoIIAA and SpoIIAB 
 
Plasmids pEAA and pEAB, containing B. subtilis spoIIAA and spoII AB as NdeI and BamHI 
inserts in vector pET3a (Novagen, Madison, Wisconsin, USA), were received from Professor 
MD Yudkin, Department of Biochemistry, Oxford University (Min et al., 1993).  
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3.2.1.1 Restriction enzyme digestion  
 
In order to confirm the integrity of the received pEAA and pEAB plasmids, the following 
restriction enzyme digestions were set up: 50 ng plasmid DNA was digested with 1 U BamHI 
(Fermentas) and 1 U NdeI (Fermentas), in the appropriate 10 x buffer (supplied by the 
manufacturer) at 37°C for 2 hours. The plasmid maps indicating the restriction sites can be 
seen in Figure 3.2. 
 
 
Figure 3.2: Plasmid maps of pEAA and pEAB, containing B. subtilis SpoIIAA and SpoIIAB, respectively. The 
ampicillin resistance gene (bla) is highlighted in yellow and the T7 promotor indicated in green. 
 
3.2.1.2 Agarose gel electrophoresis  
 
The digested products were separated by electrophoresis in a 1% agarose (Promega, 
Wisconsin, USA) gel. TAE buffer was used for electrophoresis. Ethidium bromide, a 
fluorescent DNA base interchelator (1.25 ng/ml) was included in the gel solution for DNA 
visualization. Samples were electrophoresed at 8 V.cm-1 and the bands were visualized under 
UV illumination at 312 nm, on a Bio-Rad Chemidoc Gel Documentation System (Bio-Rad 
laboratories, USA), using the QuantityOne software. 
 
3.2.1.3 Preparation of DH5 and BL21(DE3) electrocompetent cells. 
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Electrocompetent cells were prepared as described by Sambrook et al. (1989). A single 
colony was inoculated into 15 ml Luria Bertani (LB) media, and grown overnight at 37°C at 
300 rpm. Fresh LB (250 ml) was inoculated with 1 ml of the overnight culture and grown at 
37°C with shaking (220 rpm) until the cells reached early to mid-log phase (OD at 600nm of 
0.3-0.6). To harvest, the broth was transferred to cold centrifuge tubes (250 ml) and 
centrifuged at 5,000g in a Sorvall RC-5C Plus, GSA rotor (Sorvall, USA) for 10 min at 4°C. 
All the subsequent steps were done at 4°C. After the supernatant was discarded, the cells 
were washed with 250 ml ice-cold sterile water. The suspension was centrifuged at 5,000g for 
10 min. This washing step was repeated twice. After the final centrifugation step, the 
supernatant was immediately removed from the loose pellets. The pellets were resuspended 
into 10 ml ice-cold sterile 10% glycerol and incubated on ice for 30 minutes. Cells were 
subsequently harvested by centrifugation as described above, the supernatant removed by 
vacuum suction and the pellets resuspended in 800 µl ice-cold sterile 50% glycerol. This was 
divided into 100 µl aliquots and stored at -70°C. 
 
3.2.1.4 Electro-transformation of pEEA and pEAB plasmids into E. coli DH5 
 
Electrocompetent DH5 cells were thawed on ice. To 2 ng of plasmid DNA (pEAA or 
pEAB), 100 µl of electrocompetent cells was added. This was then transferred to a pre-
chilled electroporation cuvette (Hybaid, 2 mm gap) and a pulse of 2,500 V applied for 5 ms 
in a Bio-Rad MicroPulser electroporator (Bio-Rad Laboratories, Hercules, California) 
(Dower et al., 1988). LB media (1 ml) was added directly after electroporation and the cells 
were incubated for 1 hour at 37°C with shaking, and plated on LB-agar containing 100 µg/ml 
ampicillin for plasmid selection. 
 
3.2.1.5 Plasmid isolation and insert preparation 
 
In order to isolate the spoIIAA and spoIIAB genes from pEAA and pEAB, the Plasmid 
Miniprep Isolation Kit (PEQLab, Biotechnology GmbH) was used to isolate plasmid DNA 
from E. coli DH5. This DNA was then subjected to a large-scale NdeI-BamHI restriction 
enzyme digestion followed by agarose gel electrophoresis as described in Sections 3.2.1.1 
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and 3.2.1.2. For pEAA, this resulted in a plasmid backbone band of 4.6 kb, and a SpoIIAA 
insert band at 365 bp, while for pEAB there was also the 4.6 kb plasmid band and a SpoIIAB 
insert band at 422 bp. These small bands were excised from the agarose gel with a sterile 
scalpel blade, and the Zymoclean gel DNA Recovery Kit (Zymo Research Corporation, 
USA) was used to extract the DNA fragments from the agarose.  
 
3.2.1.6 Sub-cloning SpoIIAA and SpoIIAB into pET16b.  
 
pET16b (Novagen, Madison, Wisconsin, USA) was isolated, digested and agarose gel-
purified as described above for pEAA and pEAB (Section 3.2.1.4). pET16b was chosen for 
expression of SpoIIAA and SpoIIAB as it contains a nucleotide sequence to express an N-
terminal His6-tag for easier protein purification. Ligations were set up at an insert: vector 
ratio of 20:1 using T4 DNA Ligase (Fermentas, Ontario, Canada) as per the manufacturer’s 
instructions. The ligations were dried down completely using a speedy vac (Savant SC110) 
for 20 minutes, and the pellet resuspended in 1 ml 70% ethanol. This was centrifuged at 4°C 
at 10,000g for 30 minutes, the ethanol removed, the pellet air dried and resuspended in 1 µl 
dH2O. The ligation mixture was then transformed into electrocompetent E. coli BL21(DE3) 
cells, using electroporation as described in the Section 3.2.1.4. 
 
3.2.1.7 SpoIIAA and SpoIIAB protein expression  
 
E. coli BL21(DE3), freshly transformed with the pET16b plasmids containing spoIIAA and 
spoIIAB genes, were plated onto LB plates containing 100 µg/ml ampicillin. One colony was 
used to inoculate 50 ml LB containing 100 µg/ml ampicillin and incubated overnight at 37°C 
with shaking. 250 ml LB liquid medium (containing 100 µg/ml ampicillin) was inoculated 
with 2.5 ml of the overnight culture, and incubated at 37°C with shaking until an optical 
density at 600 nm of approximately 0.6 (logarithmic growth phase) was reached. 
Subsequently, IPTG (pEQ Lab Biotechnology, GmbH) was added to a final concentration of 
100 µM to induce protein expression. The cultures were then incubated at 37°C for 16 hours 
with shaking. The biomass was harvested by centrifugation at 10,000g for 10 minutes at 4°C 
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(Sorvall Plus RC-5C, GSA rotor, Sorvall, UK) and the pellet frozen for overnight storage (-
20°C). 
3.2.1.8 Extraction of the soluble protein fraction 
 
Protein extraction and purification was done utilizing the methodology essentially described 
by Liebau et al. (2002). The frozen cells were allowed to thaw on ice and resuspended in 
Buffer A. A Complete Mini, EDTA-Free protease inhibitor cocktail tablet (Roche, 
Indianapolis, USA) was added and the cells sonicated for 10 cycles of 30-second pulsed 
sonication with 30 seconds incubation on ice water between cycles [(Vibracell sonicator, 
Sonics and Materials Inc. Danbury, Connecticut, USA) with the duty cycle set to 50%)]. The 
cell debris was removed by centrifugation at 1,000g for 10 minutes at 4°C (Sorvall Plus RC-
5C, rotor SS34, Sorvall, UK), leaving the soluble protein fraction in the supernatant.  
 
3.2.1.9 SpoIIAA and SpoIIAB protein purification  
 
Affinity purification was carried out using the HIS™-select nickel affinity gel (Sigma-
Aldrich, USA) essentially as per manufacturer's manual. A 5 ml HIS™-select nickel affinity 
gel column was used during the purification of His6-SpoIIAA and His6-SpoIIAB proteins and 
entailed the following steps: The column was washed with two column volumes of deionized 
water, followed by three volumes of equilibration buffer. The clarified crude extract from the 
previous section was loaded onto the column at a flow rate of 2 to 10 column volumes per 
hour. The resin and the crude extract were incubated at 4°C for half an hour before washing 
and elution. The column was washed with 5 column volumes of wash buffer. The protein 
bound to the column was eluted from the column using 3 to 10 column volumes of elution 
buffer. Fractions of 2 ml were collected. Following collection, the column was washed with 5 
column volumes of binding buffer to remove the residual elution buffer and to restore the 
column.  
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3.2.1.10 SDS-PAGE analysis of SpoIIAA and SpoIIAB 
 
The Laemmli method for SDS-PAGE was used to analyze the purified proteins, separating 
the protein fractions based on molecular mass (Laemmli, 1970). A 4% stacking gel and 14% 
running gel were prepared. A 15 µl purified protein sample (220 µg/ml) from each of the 
eluted fractions of His6-SpoIIAA and His6-SpoIIAB was transferred to a clean 
microcentrifuge tube, and an equal volume of Laemmli loading buffer was added. The 
protein samples were denatured at 90°C for 5 minutes and loaded onto the SDS-PAGE gel. 
Electrophoresis was performed in a Tris-Glycine buffer at 200 V in a Bio-Rad Mini Protean3 
Electrophoresis system. Protein bands were visualized with PAGE staining solution, followed 
by gel destaining in a destaining solution. 
 
3.2.1.11 Protein concentration determination  
 
Protein concentration was determined by using the Quant-IT™ Protein Assay Kit (Invitrogen, 
USA) in conjunction with the QUBIT fluorimeter (Invitrogen, USA), essentially as described 
by the manufacturers. Dilutions were made when protein solution with concentrations higher 
than 1 mg/ml were expected. To 10 µl protein sample, 190 µl of the Quant-IT working 
solution (1 µl Quant-IT™ Reagent and 199 µl Quant-IT™ Buffer) was added. After a 15 
minute incubation at room-temperature, the fluorescence was read by using the QUBIT 
fluorimeter and a concentration was provided by the reader. 
 
3.2.1.12 Phosphorylation assays using radioactively labeled 32P-ATP  
 
Eluted fractions of purified His6-SpoIIAA and His6-SpoIIAB with the highest protein 
concentrations (as determined in Sections 3.2.1.10 and 3.2.1.11), were pooled. The pooled 
samples were transferred into SnakeSkin Dialysis Tubing (Pierce Biotechnology, Rockford, 
Illinois, USA) The dialysis tubing was submerged in 1L PBS buffer and slowly stirred 
overnight at 4°C to remove the imidazole and other unwanted salts present in the elution 
buffer, to eliminating interference with the enzyme assay. EasyTides ATP [-32P, 5 µCi/µl 
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packed in a 50 mM tricine buffer (pH 7.6) with green dye (Perkin Elmer Life and Analytical 
Science, Boston, USA)] was used to assess the reliability and sensitivity of kinase assays. 
SpoIIAB (kinase) and SpoIIAA (substrate) are stable for 24 hours in the assay reaction mix at 
37°C. Hence, a single step reaction (both autophosphorylation of SpoIIAB and subsequent 
trans-phosphorylation of SpoIIAA) that ran for 16 hours was used. SpoIIAA protein (950 ng) 
was mixed with 300 ng SpoIIAB substrate in SpoII phosphorylation buffer, containing 5 µCi 
-32P-labelled ATP and 1 mM ATP. All the reactions were performed in a final volume of 20 
µl. The reactions were incubated at 37°C, an equal volume Leammli loading buffer added to 
stop the reactions, and they were then heated at 90°C for 5 minutes. These reactions were 
electrophoresed on a 14% SDS-PAGE gel (as per Section 3.2.1.10).  The gels were stained 
with PAGE staining solution for 6 hours, with gentle shaking, and destained overnight in 
PAGE destaining solution containing 10% glycerol. The gels were transferred to Whatman 
3MM paper, covered with cling-wrap, and vacuum dried for 6 hours at 65°C using a slab gel 
dryer (SAVANT, Forma Scientific, USA). The radioactive gel was exposed to an X-ray film 
(Hyperfilm MP, Amersham) for 48 hours at -70°C. The film was developed by soaking it for 
2 minutes in Prefix fixer (Champion Photochemistry, RSA), washed for 2 minutes in water 
and left in PolyconA X-ray developer (May and Baker, Essex, UK) until the bands could be 
seen on the film. 
 
3.2.1.13 Site-directed mutagenesis (SDM) of SpoIIAB  
 
Two mutants of spoIIAB were created via site-directed mutagenesis. Histidine 45 was 
mutated to a glutamine (H54N) and the phenylalanine 110 was mutated to an isoleucine 
(F110I). The replacement of the His54 residue with a glutamine was performed to elucidate 
the potential role of the His54 in the phosphorylation of SpoIIAA, as other histidine kinases 
possess a conserved histidine that is autophosphorylated before transferring the phosphate to 
the substrate, while Phe110 is located within the ATP binding site of the kinase. The Phusion 
Site Directed Mutagenesis Kit (Finnzymes, Espoo, Finland) was used as described by the 
manufacturer, with some modifications on the standard protocol, as described below. For the 
H54N mutation, an NcoI restriction enzyme site was removed in a silent mutation to allow for 
selection of mutants, while for the F110I mutation, a silent PvuI restriction enzyme site was 
created. Both of these changes are indicated in the primers in Table 3.1. Oligonucleotides 
Stellenbosch University http://scholar.sun.ac.za
56 
 
were obtained from IDT (Coraville, USA) and were dissolved in TE buffer at 37°C to give a 
final stock solution concentration of 100 µM. The stock solutions were stored at -20°C. 
Working stocks of 2.5 µM were prepared.  
 
Table 3.1: Forward and Reverse oligonucleotides used for the site directed mutagenesis of SpoIIAB. These oligonucleotides 
were synthesized with 5’-phosphorylation 
 
Blue=NcoI site removed; original site was CATGG  
Green=PvuI site created; the original sequence was CGCTCT 
 
PCR amplification was used in both the mutagenesis reactions of spoIIAB, using the 
mutagenic primer pairs above. Agarose gel electrophoresis of 5 µl of each PCR reaction was 
used to verify the success of the PCR amplification. Each PCR product (~25 ng) was 
circularized with 0.5 µl Quick T4 DNA Ligase in a 5 minute reaction at room-temperature. 
The ligated DNA was transformed into E.coli DH5 by electroporation (see Section 3.2.1.4) 
and transformants selected on LM media containing 100 µg/ml ampicillin. A single colony 
was cultured in 5 ml LB, supplemented with 100 µg/ml ampicillin, and plasmid isolated 
using the E.Z.N.A. plasmid miniprep kit (Omega Bio-Tek, USA). Restriction enzyme 
analysis confirmed either the absence of the NcoI site (H54N) or the presence of the PvuI site 
(F110I).. 
 
3.2.1.14 Cloning, expression and purification of mutated SpoIIAB genes  
 
For expression and purification of the H54N and F110I His6-SpoIIAB mutants, the pET16b 
vector (Novagen, EMD Biosciences, Germany) with a N-terminal His6-tag was used for 
expression. A large scale restriction enzyme digestion was set up for H54N and F110I 
mutants of SpoIIAB, 800 ng plasmid DNA was digested with 1 U NdeI (Fermentas, USA) at 
37°C for 6 hours and followed by the addition of 1 U BamHI at 37°C for 15 hours in the 
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restriction buffer supplied by Fermentas. The digested products were separated by 
electrophoresis on a 1.5% agarose gel, as described before in Section 3.2.1.2, and the 
fragments purified from the agarose gel using the Zymoclean gel DNA Recovery Kit (Zymo 
Research, California,USA). pET16b was similarly digested and purified. Ligation reactions 
were set up at a picomole insert:vector ratio of 20:1 using T4 DNA Ligase (Fermentas, 
Ontario, Canada) as per the manufacturer’s instructions. The ligations were dried and washed 
and then transformed into E. coli DH5 electrocompetent cells by electroporation, (see 
Section 3.2.1.4). Protein expression and purification of H45N-SpoIIAB and F110I-SpoIIAB 
were performed in exactly the same manner than the non-mutated His6-SpoIIAB protein 
(Section 3.2.1.7 to Section 3.2.1.9), after transferring the plasmids to the expression host 
E. coli BL21(DE3). 
 
3.2.2 Dev two-component system proteins 
 
In various studies, attempts to obtain soluble and functional full-length HKs have consistently 
failed, consequently most studies have been performed with truncated versions of HKs that 
lack their transmembrane domains (Haydel et al., 1999). This was clearly evident when 
structural data for HKs were investigated; only the soluble domains had been crystallized. 
Transmembrane regions of some HKs are lethal to E.coli during expression, so truncation 
was used (Haydel et al., 1999). Since the immediate goal here was to demonstrate DevS’s 
biochemical function, the DevS used in this investigation was truncated to create DevS201, 
as done by Saini et al. (2004) in an attempt to improve solubility.  It was also decided to 
append the His-tag at both its C-terminal and N-terminal, in the hope of improving solubility. 
However, none of these modified DevS proteins were expressed in the soluble fractions of 
E. coli BL21(DE3) in sufficient quantities for successful purification. 
 
3.2.2.1 Oligonucleotides for devR, devS and devT amplification 
 
Oligonucleotides (see Table 3.2) were obtained from IDT (Coraville, USA) and dissolved in 
TE buffer at 37°C to give a final stock solution concentration of 100 µM. The stock solutions 
were stored at -20°C. Working stocks of 2.5 µM were prepared. The forward primers (see 
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Table 3.2, the primers labelled FW with green base pairs) were designed to incorporate an 
NdeI restriction site on the 5’ end. The reverse primers (see Table 3.2, the primers labelled 
RW with blue base pairs) were designed to incorporate BamHI restriction site on the 3’ end. 
For DevS, additional sets of primers were designed. To truncate the protein to DevS201, 
forward primer C-DevS-FW (Table 3.2,) was used with DevS-RW to leave only the 
cytoplasmic ATP binding and dimerisation fragments. Primer DevSc-RW (Table 3.2) was 
designed to allow sub-cloning of DevS or DevS201 into pET20b, which contains a C-
terminal His6-tag.  
Table 3.2: Forward and reverse oligonucleotide primers used for the amplification of different Dev gene 
fragments. 
 
Blue: BamHI cleavage site.  
Green: NdeI cleavage site. 

3.2.2.2 Cloning of Dev TCS proteins 
 
M. tb strain H37Rv (ATCC 25618) genomic DNA was used as the source of the dev genes, 
and was kindly provided by Prof I Wiid and Prof P van Helden, University of Stellenbosch. 
Each PCR reaction contained 10 ng of template, 250 nM each of forward and reverse 
primers, 200 µM dNTPs and a proofreading Taq polymerase, TaKaRa ExTaq (TaKaRa 
Biomedicals, Shuzo, Japan). The PCRs were carried out in a Mastercycler Personal 5332 
(Eppendorf Version 2.12.32) PCR machine with the following settings: 95°C for 5 minutes; 
followed by 30 cycles of: 95°C for 1 minute, 65°C for 1 minute, 72°C for 1 minute; and a 
final step at 72°C for 10 minutes. The sizes of the PCR products were confirmed by agarose 
gel electrophoresis using a 1.5% agarose gel (Section 3.2.1.2). The PCR products were 
purified from the agarose gel using the Zymoclean gel DNA Recovery Kit. The gel-purified 
PCR products were ligated into the pGem T-Easy Vector System (Promega Corporation, 
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USA) as per the manufacturer’s instructions. The ligated DNA products were transformed by 
electroporation into E. coli DH5 electrocompetent cells and transformants selected on LM 
agar containing 100 µg/ml ampicillin, 1 mM IPTG and 20 mg/ml X-GAL for blue-white 
selection (see Section 3.2.1.3 and Section 3.2.1.4).  
 
3.2.2.3 Sub-cloning the dev genes into pET vectors for expression and affinity purification. 
 
Large scale restriction enzyme digestions were set up for all the pGEM-T Easy constructs: 
800 ng of plasmid DNA was digested with 1 U NdeI (Fermentas, USA) at 37°C for 6 hours, 
followed by the addition of 1 U BamHI at 37°C for 15 hours. The digested products were 
separated by electrophoresis on a 1.5% agarose gel and the desired fragments purified from 
the agarose gel using the Zymoclean gel DNA Recovery Kit. The pET16b vector (Novagen, 
EMD Biosciences, Germany) was chosen for the N-terminal His6-tagged expression, while 
the pET20a vector (Novagen, EMD Biosciences, Germany) was used to obtain C-terminal 
His6-tagged proteins. Ligation reactions of devR, devS, devT and devS201 with pET16b, as 
well as devSc and devS201c into pET20a, were set up at a picomole insert:vector ratio of 20:1 
using T4 DNA Ligase (Promega Corporation, USA) as per the manufacturer’s instructions. 
The ligated DNA was dried, washed and transformed into E. coli DH5 and subsequently 
BL21(DE3) by electroporation, as described in Section 3.2.1.3. The plasmid maps indicating 
the different constructs produced for DevS and DevS201 can be seen in Figure 3.3, while 
Figure 3.4 shows the plasmid maps for and DevR. 
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Figure 3.3: Plasmid maps for the different DevS gene constructs. The DevS indicates the full length DevS and the C-
DevS is the truncated DevS201. As indicated, the pET20b vector contributes a C-terminal His6-tag to the protein and the 
pET16b adds an N-terminal His6-tag. The NdeI and BamHI sites used for restriction analysis are colored red. The ampicillin 
resistance gene (bla) is highlighted in yellow/green. 
 
 
Figure 3.4: The plasmid map of the response regulator DevR in pET16b. The NdeI and BamHI sites used for restriction 
analysis are colored red. The ampicillin resistance gene is highlighted in yellow. 
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3.2.2.4 Protein expression and purification  
 
Protein expression, soluble protein extraction and purification was carried out as described in 
Sections 3.2.1.7 - 3.2.1.9. For DevR and DevT, sufficient soluble protein in the cell-free 
extracts was noted to continue with non-denaturing purification of His6-tagged proteins as 
explained in Section 3.2.1.9. Neither truncation, nor the C-terminal nor N-terminal His6-tags 
improved the solubility of the expressed DevS, and another avenue needed to be explored.  
 
3.2.2.5 Matrix assisted refolding of DevS and DevS201 
 
Protein expression of C- and N-terminal his-tagged DevS and DevS201 was carried out as 
described in Section 3.2.1.7. The biomass was sonicated and then centrifuged as described in 
3.2.1.8. The pellet included the insoluble proteins sequestered in inclusion bodies, and was 
dissolved in denaturation buffer (using 8M urea as solubilisation agent) and incubated at 
37°C for 2 hours, shaking at 220 rpm. The remaining insoluble proteins were removed by 
centrifugation for 5 minutes at 3,500g. The solubilised denatured proteins in the supernatant 
were loaded onto a 5 ml column containing pre-equilibrated HIS™-select nickel affinity gel 
(Sigma-Aldrich, USA) and incubated for 30 minutes at room temperature. The unbound 
protein was collected as flow-through. The column was washed with 3 column volumes of 
denaturation buffer containing 20 mM imidazole and then washed stepwise with renaturation 
buffer containing decreasing concentrations of urea (8 M to 1 M). The column was 
subsequently washed with 2 bed volumes of renaturation buffer without urea to further 
remove any contaminating E. coli proteins and remaining urea. The bound His6-tagged 
protein was eluted with 20 ml renaturation buffer containing 250 mM imidazole, in fractions 
of 2 ml. The fractions were analyzed by SDS-PAGE (Section 3.2.1.10) and the peak fractions 
were pooled, dialyzed against PBS buffer, and stored at 4°C.  
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3.2.2.6 Radioactive phosphorylation assays  
 
Phosphorylation assays using -32P-labeled ATP (EasyTides), 5 µCi/µl packed in a 50 mM 
tricine buffer (pH 7.6) with green dye (Perkin Elmer Life and Analytical Science, Boston, 
USA) was used for the kinase assays. The phosphorylation of the Dev two-component system 
occurs in a two step reaction that is different from the SpoII system that was described in 
Section 3.1.12. According to Saini et al. (2002), the maximum signal for phosphorylated 
DevR (DevR~P) is obtained within 2 minutes and total dephosphorylation of DevR occurs 
within 10 minutes. To detect autophosphorylation of DevS, purified and refolded DevS (30 
µM) was incubated with 5 µCi of [-32P]ATP in 20 µl Dev phosphorylation buffer at 25°C. 
This autophosphorylation reaction was terminated after 1 hour with Laemmli loading buffer, 
followed by 5 minutes of heating at 90°C. For the phosphotransfer assays, DevR (15 µM) 
were added to the autophosphorylated kinase (DevS~P). The reactions were terminated after 
2 minutes. The same phosphorylation reaction was repeated by replacing DevS with DevT, 
since it is hypothesized that autophosphorylation of DevT might also initiate phosphotransfer 
to DevR. These reactions were analyzed on 12% SDS-PAGE gel (as per Section3.2.1.10). 
After destaining, the gel was rinsed in gel storage buffer for about 15 minutes in order to try 
and prevent unnecessary cracking of the gels during the drying procedure. The gels were 
transferred to Whatman paper, covered with cling-wrap, and dried for 6 hours at 65°C using a 
slab gel dryer (SAVANT, Forma Scientific, USA). The radioactive gel was exposed to an X-
ray film (Hyperfilm MP, Amersham) for 48 hours at -70°C. Subsequently the film was 
soaked for 2 minutes in Prefix fixer (Champion Photochemistry, RSA), washed for 2 minutes 
in water and left in PolyconA X-ray developer (May and Baker, Essex, UK) until the bands 
could be seen on the film. 
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3.3 Results 
 
3.3.1 Bacillus subtilis SpoIIAA and SpoIIAB  
 
A representative HK-like two-component signalling system, B. subtilis SpoIIAA and 
SpoIIAB, was chosen as a model to set up an investigation into HK active sites. After sub-
cloning spoIIAA and spoIIAB from pEAA and pEAB into pET16b, the plasmids were 
transformed into E. coli DH5 cells via electroporation. Plasmid-containing cells were 
selected with 100 µg/ml ampicillin. After plasmid isolation, the presence of the spoIIAA and 
spoIIAB genes in the plasmids was confirmed with restriction enzyme digestion using NdeI 
and BamHI.  SpoIIAA and SpoIIAB were successfully expressed in the soluble fractions of 
E. coli expression host BL21(DE3), in sufficient quantities for affinity purification, as can be 
seen in the 14% SDS-PAGE gel shown in Figure 3.5. After the presence of the proteins in the 
soluble fractions was confirmed, the fractions were used in nickel affinity chromatography. 
From the 14% SDS-PAGE gel in Figure 3.6, it was evident that the protein affinity 
purification was successful, since there were bands of the expected size, at approximately 14 
and 17 kDa. Contaminating bands were observed above 30 kDa molecular weight. The 
purified proteins were then dialyzed overnight in PBS 
 
 
Figure 3.5: 14% SDS-PAGE analysis of the soluble protein expression of SpoIIAA and SpoIIAB. Lane M: Protein 
PAGERuler (Fermentas). Lane 1: SpoIIAA soluble fraction. Lane 2: SpoIIAB soluble fraction. The molecular mass of the 
relevant bands on the PAGERuler is indicated on the left side, provided by Fermentas. The boxes indicate SpoIIAA at 14.2 
kDa (lane 1) and SpoIIAB at 14.7 kDa (lane 2). 
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Figure 3.6: 14% SDS-PAGE analysis after affinity protein purification with HIS™-select nickel affinity gel . Lane M: 
Protein PAGERuler (Fermentas). Lane 1: Sample of SpoIIAA that was loaded on the HIS™-select nickel affinity gel. Lane 
2: Purified SpoIIAA (20.7 µg/ml). Lane 3: SpoIIAA protein sample loaded on the HIS™-select nickel affinity gel. Lane 4: 
Purified SpoIIAB (40.8 µg/ml). The molecular mass of the relevant bands on the PAGERuler is indicated on the left side, 
provided by Fermentas. 
 
The phosphorylation of SpoIIAA by SpoIIAB was determined by means of radio-active 
phosphorylation assays. The end result of the SpoII phosphorylation assay is a stable 
phosphorylated protein, (SpoIIAB~P during autophosphorylation and SpoIIAA~P during 
trans-phosphorylation reactions), as shown in Figure 3.7. In Figure 3.7, lane 1 shows the 
autophosphorylated SpoIIAB, lane 2 indicates no autophosphorylation for SpoIIAA, while 
the trans-phosphorylation of SpoIIAA by SpoIIAB is shown in lanes 3 and lane 4. 
 
 
Figure 3.7: Radio-active phospho-transfer analysis of SpoIIAA and SpoIIAB protein activity. Lane 1: 
Autophosphorylation of SpoIIAB (kinase) Lane 2: Negative control SpoIIAA (substrate). Lane 3 and 4: SpoIIAA and 
SpoIIAB in a phosphorylation assay. Lane M indicates the molecular mass of the relevant bands on the PAGERuler, as 
provided by Fermentas. 
 
Stellenbosch University http://scholar.sun.ac.za
65 
 
In order to show that the site-directed mutagenesis of SpoIIAB was successful, NcoI 
(removed in H54N) and PvuI (added in F110I) restriction enzyme digestions were done with 
both mutated and wild-type spoIIAB plasmid constructs, which can be seen in Figure 3.8. 
The H54N mutation removes one of the two NcoI restriction site present in the construct, 
therefore the mutant will present as a single band at 2.8 kb (Figure 3.8, lane 2) but the wild-
type will have two bands (2.6 kb and 0.2 kb) seen in lane 3. The 0.2 kb band cannot be seen 
on the gel because it is too small. The F110I mutant adds a second PvuI site; consequently the 
wild type has a single band at 2.8 kb (lane 6) and the mutant have two bands (1.9 kb and 0.9 
kb) in lane 7. After sub-cloning the H54N- and F110I-mutated spoIIAB genes into pET16b 
for His-tagged expression, the mutated proteins were expressed as described for the wild-
type, and expression analyzed on SDS-PAGE gels. 
 
 
Figure 3.8: Restriction enzyme digestion of the DNA from mutated and non-mutated SpoIIAB. Lane M: 1 kb DNA 
ladder (New England Biolabs). Lane 2: H54N-SpoIIAB: NcoI. Lane 3: Wild type SpoIIAB: NcoI (2.6 kb and 0.2 kb not 
visible). Lane 4: Wild type SpoIIAB: XbaI. Lane 5: H54N-SpoIIAB: XbaI. Lane 6: Wild type SpoIIAB: PvuI (single band 
2.8 kb). Lane 7: F110I-SpoIIAB: PvuI (1.9 kb and 0.9 kb). 
 
The lack of phosphotransfer by the H54N and F110I to SpoIIAA, compared to the control 
phosphorylation SpoIIAB, was shown by means of radio-active phosphorylation assays 
(Figure 3.9). Lane 2 shows the autophosphorylations of SpoIIAB and the consequent 
transphosphorylation of SpoIIAA in Lane 5. Autophosphorylation was absent for the H54N 
mutant in lane 3, with no transphosphorylation in lane 6. Similarly, no autophosphorylation is 
seen in lane 4 for the F110I mutant and its phosphotransfer reaction between F110I and 
SpoIIAA (lane 7). 
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Figure 3.9: Phosphorylation analysis: The purification of the mutants on a 14% SDS-PAGE (right) and the 
radiogram of the experiment (left). One the 14% SDS-PAGE (right): Lane M: PageRuler Protein Ladder. Lane 1: Purified 
SpoIIAB. Lane 2: Purified H54N. Lane 3: Purified F110I. Lane 4: Purified SpoIIAA. The radiogram of the experiment: 
Lanes M: PageRuler Protein Ladder. 1: SpoIIAB (autophosphorylation reaction). Lane 2: H54N (autophosphorylation 
reaction). Lane 3: F110I (autophosphorylation reaction). Lane 4: Phosphotransfer reaction between SpoIIAB and SpoIIAA. 
The molecular mass of the relevant bands on the PAGERuler is indicated on the left side, as provided by Fermentas. On the 
radiogram the 15 kDa 20 kDa and 50k Da bands of the PAGE ruler were indicated during development with a permanent 
marker. 
 
 
3.3.2 M. tb two-component signal transduction systems  
 
The full-length devR, devS and devT genes, as well as the truncated devS201, were amplified 
by PCR, with the primers designed to flank the genes in the genome of M. tb H37Rv strain. 
The final PCR products are shown in Figure 3.10. After cloning the PCR products into 
pET16b (devR, devS, devS201 and devT) and pET20a (devSc and devS201c), respectively, the 
presence of the dev genes in the plasmid was confirmed with restriction enzyme digestion 
(data not shown).  
 
Figure 3.10: PCR products from gene amplification from M. tb H37Rv strain. Lanes M: 1 kb Base pair ladder (New 
England Biolabs). Lane 1: devR (654 bp). Lane 2: devS (1737 bp). Lane 3: devT (807 bp). Lane 4 devS (1737 bp) Lane 5: 
DevS201 (650 bp). Lane 6: devS201c (650 bp). 
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The full length N-terminal His6-tag DevR and DevT proteins were both expressed in the 
soluble fractions of E. coli BL21(DE3), as in Figure 3.11, lanes 1 and 3, respectively. DevS 
was only present in the insoluble fraction as can be seen in Figure 3.11, lane 5. Soluble DevR 
and DevT were successfully purified by affinity purification, using HIS™-select nickel 
affinity gel chromatography. From the SDS-PAGE gel in Figure 3.12, it was evident that the 
purification of DevR (lanes 2 and 3) as well as DevT (lanes 4 and 5) was successful. Initial 
attempts at soluble expression of sufficient quantities of both full length DevS and truncated 
DevS210 did not succeed, whether containing an N- or C-terminal His-tag, although there 
were high levels of expression of insoluble protein, as can be seen in Figure 3.13 (lanes 4-6).  
 
 
Figure 3.11: 12% SDS-PAGE analysis of protein expression of DevR, DevS and DevT. Lane M: Protein PAGERuler 
(Fermentas). Lane 1: DevR (25 kDa without His6-tag) soluble fraction. Lane 2: DevS soluble fraction (62.3 kDa without 
His6-tag). Lane 3: DevT soluble fraction (28 kDa without His6-tag). Lane 4: DevR insoluble fraction (pellet). Lane 5: DevS 
insoluble fraction (pellet). Lane 6: DevT insoluble fraction (pellet). The molecular mass of the relevant bands on the 
PAGERuler is indicated on the left side, as provided by Fermentas. 
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Figure 3.12: 12% SDS-PAGE analysis of DevR and DevT proteins purified by affinity purification with HIS™-select 
nickel affinity gel. Lane M: PageRuler Protein Ladder. Lane 1: Purified DevR. Lane 2: Purified DevR Lane M: PageRuler 
Protein Ladder. Lane 4: Purified DevT Lane 5: Purified DevT. The molecular mass of the relevant bands on the PAGERuler 
is indicated on the left side, as provided by Fermentas. 
 
 
Figure 3.13: 12% SDS-PAGE analysis of protein expression of the C-terminal His6-tagged DevSc, the truncated N-
terminal His6-tagged DevS210 and the truncated C-terminal His6-tagged DevS210c. Lane M: PageRuler Protein 
PAGERuler (Fermentas). Lane 1: BL21(DE3) pellet fraction without any construct. Lane 2: DevS210c insoluble fraction 
(26.5 kDa). Lane 3: DevSc insoluble fraction (62.3 kDa). Lane 4: DevS210 insoluble fraction (26.5 kDa). Lane 5: DevS210c 
soluble fraction. Lane 6: DevSc soluble fraction. Lane 7: DevS210 soluble fraction. The molecular mass of the relevant 
bands on the PAGERuler is indicated on the left side, as provided by Fermentas. 
 
Another method to resolve the insolubility of DevS was to use matrix assisted refolding, 
which was carried out according to Saini et al. (2002). As indicated by Figure 3.14, this 
method worked very efficiently for all the constructs DevSc, DevS201 and DevS201c.  
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Figure 3.14: 12% SDS-PAGE analysis of refolded truncated N-terminal His6-tagged DevS201, truncated C-terminal 
His6-tagged DevS201c and full-length C-terminal His6-tagged DevSc proteins, purified by matrix assisted refolding on 
HIS™-select nickel affinity gel. Lane M: PageRuler Protein Ladder. Lane 1: Purified DevS201 (180 µg/ml). Lane 2: 
Purified DevS201c (82 µg/ml). Lane 3: Purified DevSc (520 µg/ml). The molecular mass of the relevant bands on the 
PAGERuler is indicated on the left side, as provided by Fermentas. 
 
After the successful expression of the kinases and substrate proteins had been confirmed on 
SDS-PAGE gels, the protein activity was identified by means of radio-active phosphorylation 
assays. Firstly, the autophosphorylation capacity of the different DevS constructs needed to 
be determined, in order to ascertain whether the truncation caused any loss of 
autophosphorylation ability. This reaction is problematic because the phosphorylated form of 
DevS construct is transient. Figure 3.15 shows no autophosphorylation, which may be due to 
the unstable nature of the phosphorylated kinase. However, trans-phosphorylation of DevR 
was successfully shown. Figure 3.16, lane 3 shows DevR phosphorylation when combined 
with DevS201, showing that truncation of DevS does not interfere with its functionality. No 
phosphorylation of DevR was shown with either the full length DevS or the DevT kinase.  
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Figure 3.15: Autophosphorylation assay: 12% SDS-PAGE (left) and the radiogram of the assay (right). Lane M: 
PageRuler Protein Ladder (Fermentas). Lane 1: DevT (sample 1). Lane 2: DevT (sample 2). Lane 3: DevS201. Lane 4: 
DevSc. Lane 5: DevS201c. 
 
 
Figure 3.16: Trans-phosphorylation assay: 12% SDS-PAGE (left) and the radiogram of the assay (right). Lane M: 
PageRuler Protein Ladder. Lane 1: DevT (sample 1). Lane 2: DevT (sample 2) Lane 3: DevS201. Lane 4: DevSc. Lane 5: 
DevS201c. The molecular mass of the relevant bands on the PAGERuler is indicated on the left side, as provided by 
Fermentas. On the radiogram the 25 kDa and 50k Da bands of the PAGE ruler were indicated during development. 
 
3.4 Discussion 
 
At the outset, the aim was to use the SpoII TCS as a model system to demonstrate functional 
kinase expression and allow for the optimization of the radio-active phosphorylation kinase 
assay. The following was successfully carried out:  
• The histidine kinase SpoIIAB and the substrate SpoIIAA was successfully cloned, 
expressed and purified using HIS™-select nickel affinity gel.  
• The autophosphorylation of SpoIIAB and the subsequent phosphotransfer to SpoIIAA 
was visualized using radio-labelled ATP. 
• The protocols for performing site-directed mutagenesis were developed and tested by 
making two SpoIIAB mutations. 
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• The sensitivity of the phosphorylation assay was measured by comparing the wild type 
SpoIIAB activity to the mutant SpoIIAB activity.  
Functional expression and purification of the Dev TCS components was undertaken: N-
terminal His6-tagged DevR and DevT were expressed in moderate levels of solubility and the 
proteins purified on a native HIS™-select nickel affinity gel. Both N-terminal and C-terminal 
His6-tagged DevS were expressed insolubly and aggregated to form inclusion bodies. 
It has been demonstrated that removal of the N-terminal membrane-associated region of 
DevS should also increase solubility (Saini et al., 2004a). Two different truncated forms of 
DevS were therefore produced: N-terminal His6-tagged truncated DevS (DevS201) and C-
terminal His6-tagged truncated DevS (DevS201c). Neither of the truncations improved the 
solubility of the DevS, but denaturing HIS™-select nickel affinity purification in the form of 
matrix assisted refolding led to the production of soluble DevS protein (Saini et al., 2002). 
The proteins were denatured with high concentrations of urea (6M-8M) and then loaded onto 
the HIS™-select nickel affinity gel. By systematically decreasing the concentration of urea 
(from 8M tot 0.5M) in the buffer, the proteins were allowed to slowly refold to their native 
conformation while still bound to the column. When the concentration of urea reached zero, 
the refolded proteins were eluted from the column with an increased concentration of 
imidazole.  
The question remained as to whether DevS201 has the same functionality as DevS with 
regards to autophosphorylation and phosphotransfer. The autophosphorylation data was 
inconclusive. As shown in Saini et al. (2004a), the phosphorylated DevS is intrinsically 
stable; even though various attempts was made to get the same result it was unsuccessful. 
Saini et al. (2002) showed that phosphorylated DevS in the presence of DevR was labile and 
rapidly transferred its phosphoryl group to generate the phosphorylated DevR. DevS 
autophosphorylation appears to be transient. Consequently no autophosphorylation of DevS 
could be seen in the phosphorylation reactions as phosphorylated DevS was not sufficiently 
stable or the phosphoryl group was transferred to DevR before the reaction could be stopped. 
The positive results from the phosphotransfer assays between DevS201 and DevR proved 
functionality of the truncated form of the kinase. This allowed for further investigations to be 
carried out on the DevR and DevS interactions 
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Chapter 4 In silico and in vitro DNA 
binding analysis of DevR  
 
 
4.1 Introduction 
 
4.1.1 Known information on how DevR binds DNA 
 
4.1.1.1 The 20 bp palindromic consensus sequence 
 
The DevR response regulator functions as a transcription factor of the two-component 
response regulator class (Dasgupta et al., 2000). Park et al. (2003) searched for shared 
sequence motifs upstream of hypoxic response genes by doing a computer analysis with the 
motif discovery program YMF (Sinha and Tompa, 2002). The analysis uncovered a 20 bp 
palindromic consensus sequence 5-TTSGGGACTWWAGTCCCSAA-3 (where S = C/G; W 
= A/Ta variation of which could be found upstream of 84% of the M. tb genes which are 
rapidly induced at least twofold by hypoxia (Park et al., 2003). Previous research suggested 
that bases G4, G5, G6, and C8 in the 20 bp palindromic consensus sequence are crucial for 
DNA interaction with DevR (Park et al., 2003; Wisedchaisri et al., 2008). Mutating G4 to A 
could be tolerated for DevR and DNA interaction, but no activity was present as it is the site 
of phosphorylation by DevS. In contrast, G5, G6, and C8 nucleotides were conserved in most 
of the motifs binding to DevR, forming the basis of recognition (Chauhan and Tyagi, 2008a). 
NarL, a well-studied response regulator and transcription factor, interacts specifically with its 
cognate DNA motif in its phosphorylated form. Similarly, phosphorylated and not 
unphosphorylated DevR forms a DNA interaction with sequences containing the palindromic 
consensus sequence (Chauhan and Tyagi, 2008a). The Asp54 site of phosphorylation and 
other amino acids involved in DNA binding can be seen in Figure 4.1. The goal of this 
investigation was to resolve the regulatory function of DevR, by determining the binding of 
DevR to recognition sequences in narK and hspX, both hypoxia-regulated genes. NarK is a 
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nitrate/nitrite transporter protein. The increase in nitrate reduction under hypoxic conditions 
is attributed to the increase in nitrate/nitrite transport (Chauhan and Tyagi, 2008a). The 
intergenic regions of narK contain three putative Dev boxes (recognition motifs), to which 
DevR can bind (Chauhan and Tyagi, 2008a). During latency, expression of the hspX protein 
is up-regulated. The hspX promoter sequence includes multiple DevR binding sites which 
overlap with the -35 promoter element (Chauhan and Tyagi, 2008b). Since both of these 
elements contains DevR binding sites and were previously proven to bind DevR, they were 
used to study the influence that mutations will have on DevR binding. 
 
 
Figure 4.1: The DevR phosphorylation site. The side chains of Asp54 (highlighted in yellow), Thr82 and Asp87 in the N-
terminal domain (highlighted in purple), Tyr101 and Lys104 in the linker (highlighted in blue), Gln199 and Glu206 in the C-
terminal domain (highlighted in green) are shown as stick models (Wisedchaisri et al., 2008). These amino acids were 
hypothesized by Wisedchaisri et al. (2008) to play a role in the trans-phosphorylation of DevR by DevS. 
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4.1.1.2 Structural information on DevR  
 
Wisedchaisri et al. (2008) reported crystal structures of full-length unphosphorylated DevR at 
2.2 Å resolution and its C-terminal DNA binding domain at 1.7 Å resolution. DevR forms a 
dimer related by a non-crystallographic 2-fold axis (Figure 4.2). The two-helix linker (helices 
5 and 6) from both subunits form a four-helix, as indicated in blue and gray in Figure 4.2. 
The second part of the dimerization interface comes from interactions between the N-terminal 
domain helices 2 and 3 of one subunit and the C-terminal domain helices 7 and 8 of the 
other subunit (Wisedchaisri et al., 2008). Wisedchaisri et al. (2005) hypothesized that the 
following amino acids play a role in the DevR–DNA complex: Lys179, Lys182, and Asn183 
could interact with nucleotide bases, while Arg196, Thr198, Val202, and Thr205 could 
contribute to the dimerization interface. Further experimental analysis is necessary in order to 
understand the binding of DevR to these consensus sequences and to determine the nature of 
these interactions.  
 
 
Figure 4.2: Crystal structure of full-length DevR. (A) The DevR monomer. The structure is shown in purple for the N-
terminal domain, blue for the linker, and green for the C-terminal DNA binding domain. (B) The DevR dimer, subunit A is 
shown in (A). Subunit B is shown in gray. A sulfate molecule (shown as a stick model) is found in the dimer interface 
between the two DevR molecules (Wisedchaisri et al., 2008). 
 
4.1.2 Electrophoretic Mobility Shift Assay (EMSA) 
 
The interaction of proteins with DNA is central to many cellular processes. EMSA is a 
technique used to study DNA-protein interactions. This technique is based in the observation 
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that DNA-protein complexes migrate more slowly than unbound DNA fragments when 
electrophoresed on a native polyacrylamide gel, and is also referred to as mobility shift or gel 
retardation assays (Fried and Crothers, 1981; Garner and Revzin, 1981).  
4.2 Methods 
 
4.2.1 DevR binding DNA modelling  
 
Structural data of DevR binding to a 20 bp palindromic sequence containing inverted repeats 
of the G4G5G6A7C8T9  recognition motif were available in two different PDB database 
structures: 1ZLK and 3C3W (Wisedchaisri et al., 2008). Discovery Studio (DS) was used to 
visualize all the hydrogen bonds that could potentially form between the protein and DNA. 
DS was also used to model mutations in the identified amino acid residues. The structural 
modelling of the mutations was followed up by biochemical investigations in order to test 
predictions made using the model regarding residues that may be important to the binding of 
DNA.  
 
4.2.2 Generation of PCR fragments for DNA-protein binding 
 
M. tb strain H37Rv (ATCC 25618) genomic DNA was used as the source of the narK and 
hspX target DNA fragments. The primers used for PCR amplification of these DNA 
fragments are shown in Table 4.1. A temperature gradient PCR was set up for all the different 
constructs to determine the optimal annealing temperatures. The optimum annealing 
temperature was determined to be 53.3°C. Each PCR reaction contained 50 ng template DNA 
(received from Prof P v Helden, University of Stellenbosch, South Africa), 250 nM of each 
forward and reverse primers (from IDT Coraville, USA) as shown in Table 4.1, 200 µM 
dNTPs and 1 U TaKaRa ExTaq (TaKaRa Biomedicals, Shuzo, Japan). The PCR was carried 
out in a Mastercycler (Personal 5332 Eppendorf Version 2.12.32) with the following settings: 
95°C for 5 minutes was followed by 30 cycles of: 95°C for 1 minute, 53.5°C for 1 minute, 
72°C for 1 minute, and a final extension at 72°C for 10 minutes. The size of the PCR 
products was confirmed by agarose gel electrophoresis using a 1.5% agarose gel (as per 
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Section 3.2.1.2). The PCR products of the respective target DNA fragments were purified 
from the agarose gel with the Zymoclean gel DNA Recovery Kit (see Section 3.2.1.5). 
 
Table 4.1 HspX and NarK primers designed to generate PCR fragments for DNA-protein binding 
 
4.2.3 Site directed mutagenesis (SDM) of DevR 
 
Point mutations in DevR were created to elucidate the identified amino acids role in DNA-
protein binding: Lys179 was changed to isoleucine (K179I), Lys182 was changed to 
isoleucine (K182I), Asp183 to leucine (N183L), and Tyr205 to valine (T205V). The Phusion 
Site Directed Mutagenesis Kit (Finnzymes, Espoo, Finland) was used as described by the 
manufacturer. Mutations of the polar amino acids K179I, K182I and N183L to non-polar 
amino acids could elucidate their potential role in the binding of DevR to the DNA regions. 
The T205V mutation is located on the DevR dimerization interface and it might interfere with 
DevR dimerization or the binding to DevS during phosphorylation. For the K179I mutation, a 
PvuI restriction enzyme site was created by silent mutation to allow for selection of mutants, 
while for the K182I and N183L mutation, a SnaBI restriction enzyme site was created. For 
the T205 mutation, an AflII restriction enzyme site was created to allow for selection of 
mutants. All of these changes are indicated in Table 4.2. The primers were synthesized by 
IDT (Coraville, USA) and were dissolved in TE buffer at 37°C to give a final stock solution 
concentration of 100 µM. Working stocks of 2.5 µM were prepared. PCR amplification was 
used in all the mutagenesis reactions, using the mutagenic primers in Table 4.2 and M. tb 
strain H37Rv (ATCC 25618) genomic DNA was used as the template. The PCR parameters 
were adjusted to suit the Phusion Hot Start DNA polymerase: the enzyme activation took 
place at 98°C for 30 seconds, followed by 25 cycles of: denaturation at 98°C for 30 seconds, 
annealing for 3 minutes at 71.9°C (for K179I, K182I and N183L) or 67.6°C (T205V), and 
extension at 72°C for 30 seconds, followed by a final extension was 72°C for 5 minutes. 
During ligation, 25 ng of each purified PCR product was circularized with 0.5 µl Quick T4 
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DNA Ligase in a 5 minute reaction, with 2x Quick ligation buffer at room-temperature. These 
ligation reactions were transformed into E. coli DH5 electrocompetent cells by 
electroporation and transformants selected on LB agar containing 100 µg/ml ampicillin (see 
Section 3.2.1.4) A resultant colony was cultured in 5 ml LB media containing 100 µg/ml 
ampicillin, and the E.Z.N.A. plasmid miniprep kit (Omega Bio-Tek, USA) was used to obtain 
plasmid DNA for restriction enzyme verification. The plasmids from the respective mutations 
were digested with the selected restriction enzymes to confirm the presence of the mutations. 
Following the confirmation of the silent mutations, the mutations were confirmed by 
sequencing (Inqaba Biotec, Pretoria, South Africa), and the plasmids transformed into the E. 
coli expression host Bl21(DE3) cells by electroporation.  
Table 4.2: PCR primers used to insert point and silent mutations in DevR. 
 
The wild type codons correspond to the codons on the primer where the point mutations were made to change to amino acid (highlighted 
turquoise). The codons highlighted in grey were changed to form silent mutations, inserting a restriction enzyme site that can be used for 
screening. 
 
4.2.4 DevR-DNA Binding assay 
 
Wild-type DevR, DevS and DevT, as well as the DevR mutants prepared in Section 4.2.3, 
were expressed and purified as previously described in Section 3.2.2.4 and 3.2.2.5. 
Phosphorylation of DevR was performed in two ways: chemical phosphorylation with acetyl 
phosphate, or enzymatic phosphorylation with DevS. Acetyl phosphate has been shown to 
activate response regulators as efficiently as their corresponding kinases (McCleary and 
Stock, 1994). The DevR-DNA binding reaction took place in standard EMSA binding buffer, 
with 15-20 ng hspX or narK DNA, 10 - 40 µg DevR protein and 50 mM acetyl phosphate. 
For enzymatic phosphorylation, 20 µg DevS or DevT was used and 9.6 mM ATP was added. 
The reactions were incubated at 37°C for 30 minutes, then 2 µl Fermentas Orange DNA 
Loading Dye was added to stop the reaction. 
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4.2.5 Native PAGE 
 
Non-denaturing TBE-polyacrylamide gels were used to resolve the DNA-DevR interactions. 
A 4% native stacking gel and a 5% running gel were used, with gels pre-run at a constant 
voltage of 80 V until the current has stabilised, using 0.5% TBE. This was done to remove all 
traces of ammonium persulphate, to evenly distribute the ions throughout the gel and to 
maintain a constant gel temperature during electrophoresis. The 20 µl DevR-DNA binding 
reactions from Section 4.2.4 were separated at 120 V in a Bio-Rad Mini Protean3 
electrophoresis system, in 0.5% TBE running buffer. The gel was stained with ethidium 
bromide in 0.5% TBE solution for one hour and the DNA bands were visualized and 
photographed under UV light using the Bio-Rad ChemiDoc system (Bio-Rad Laboratories, 
USA), with QuantityOne software. 
 
4.2.6 Phosphorylation of DevR via Acetyl phosphate and Mass Spectrometry (LC-MS 
using C4 Jupiter column) 
 
Mass spectrometry was done by Dr. S Stoychev (CSIR, Pretoria, South Africa). Two samples 
were provided: unphosphorylated DevR in PBS buffer pH 7.4 (concentration of 300 µg/ml 
therefore 11.5 pmol/µl) and DevR phosphorylated with acetyl phosphate in MS 
phosphorylation buffer pH 7.4 (concentration of 144 µg/ml equivalent to 5.5 pmol/µl). The 
sample analysis was done as follows: 2 µl of unphosphorylated DevR (approximately 20 
pmol per experiment) and 10-30 µl of phosphorylated DevR (approximately 55-65 pmol per 
experiment) were loaded. Protein desalting was done on a C4 Jupiter Reverse phase column 
(1x150 mm) at 150 µl/min using a gradient wash step starting at 20% MS buffer B, 
increasing to 80% MS buffer B over a period of 10 minutes, then a continuous wash at 80% 
MS buffer B for 5 minutes and then decreasing the concentration again to 20% MS buffer B 
(where buffer A: 0.5% acetonitrile and 0.1% formic acid and buffer B: 100% acetonitrile and 
0.1% formic acid). The C4 column is connected via a 6 port switch valve to QSTAR-ELITE 
with Turbo-Ion source installed. Data acquisition performed in TOF-MS mode using a scan 
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range of 600-1700 mz. During data processing the protein isotopic profiles were 
deconvoluted by the “Bayesian Protein Reconstruct” tool found in Analyst QS v2.0.  
4.3 Results 
 
4.3.1 In silico modelling of DevR binding DNA  
 
In silco modelling of DevR binding to a DNA target identified three amino acids that 
potentially play a role in the binding of DevR to the promoter DNA of genes it regulates, 
namely Lys179, Lys182 and Asp183 (Figure 4.3). Thr205 was thought to play an important 
role in the dimerization of the DevR molecules upon binding DNA. The changes in DevR 
protein structure caused by the mutations K179I, K182I and N183L were modelled in silico, 
and the collective effect is shown in Figure 4.4. The wild type DevR is shown in Figure 4.4 
(A). A positively charged region comprising the two lysines and the asparagine clustered 
together, is shown in blue. The red indicates a more negatively charged region and white 
indicates a neutral charge. When the K179I, K182I and N183L mutations are made (B), there 
is a net loss of charge in that region of the protein indicated by the white coloured region. 
Spatially, the bulky side chains of the wild type K179 and K182 (C) are replaced by a smaller 
side chain I179 and I182 (D). Both the charge and the size differences could possibly affect 
the binding of DevR to its target DNA.  
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Figure 4.3: In silico modelling of DevR interacting with a target DNA fragment identified amino acids to be mutated: 
K179I, K182I, N183L and T205V. The amino acids that were mutated are highlighted in yellow A) K179, B) K182, C) 
N183. In D) the T205 that sits on the interface of the dimer can be seen. 
 
 
Figure 4.4: Implications of mutations on the charge and size of the DevR. (A) shows the wild type DevR and (B) shows 
the mutated DevR with emphasis on the charge change that occurs during mutations. The more positive charged regions are 
shown in blue, while red indicates more negatively charged regions and white regions are uncharged. (C) shows the wild 
type having more bulky side chains than the mutant DevR (D). K179 and K182 have larger side chains than I179 and I182, 
similarly N183 is bulkier than L183. 
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4.3.2 Electrophoretic Mobility Shift Assay 
 
The narK and hspX target DNA fragments were amplified by PCR, with the primers designed 
to flank the DNA fragments in the genome of M. tb H37Rv strain. The final PCR products 
are shown in Figure 4.5. The hspX and narK fragments had expected sizes of 186 bp and 277 
bp, respectively.  
 
Figure 4.5: PCR products from NarK and HspX amplification from M. tuberculosis H37Rv strain. Lane M: MassRuler 
Express, Low range (forward) (Fermentas). Lane 1: HspX 186 bp. Lane 2: NarK 277 bp. 
 
Dev proteins were purified using matrix assisted refolding, and results are shown in Figure 
4.6. Phosphorylation of DevR can be done in two ways, either chemically by using acetyl 
phosphate or enzymatically by using DevS or DevT and ATP (McCleary and Stock, 1994; 
Saini et al., 2004b). Results shown in Figure 4.7 indicate that the acetyl phosphate and DevS 
methods were equally effective, with the phosphorylated DevR resulting in the same binding 
(shift) effect for both ways of phosphorylation. In Figure 4.7, the shift seen in lanes 1-3 is as 
result of DevR being phosphorylated by acetyl phosphate. Lanes 5-7 shows the resulting shift 
caused by DevT phosphorylation, which was much less effective. Different concentrations of 
DevS and truncated DevS201 were used to phosphorylate DevR and the resulting shifts can 
be seen in Figure 4.7 (lanes 8-16). Since using acetyl phosphate is less variable, it was 
decided to continue using that protocol.  
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Figure 4.6: A 12% SDS-PAGE analysis of refolded DevR, DevT, truncated N-terminal His6-tagged DevS201, 
truncated C-terminal His6-tagged DevS201c and full-length C-terminal His6-tagged DevSc proteins, purified by 
matrix assisted refolding on HIS™-select nickel affinity gel. Lane M: PageRuler Protein Ladder (Fermentas). Lane 1-2: 
Purified DevR. Lane 3: Purified DevT. Lane 4: Purified DevS201. Lane 5: Purified DevS201c. Lane 6: Purified DevSc. 
 
 
 
Figure 4.7: Comparison of the phosphorylation methods used to phosphorylate DevR. Lane M: O'GeneRuler™ 50 bp 
DNA Ladder (Fermentas). Lane 1- 3: NarK with DevR (phosphorylated by 50 mM acetyl phosphate). Lane 4: NarK without 
DevR. Lane 5-7: NarK with DevR phosphorylated by DevT. Lane 8-10: NarK with DevR phosphorylated by DevS201. Lane 
11: NarK without DevR. Lane 12-14: NarK with DevR phosphorylated by 50 mM acetyl phosphate. Lane 15-17: NarK with 
DevR phosphorylated by DevS201c. Lane 18-20: NarK with DevR phosphorylated by DevSc. The DevR concentration is 
indicated. The NarK concentration was kept constant. 
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4.3.3 Site Directed Mutagenesis of DevR 
 
The first step in producing mutants of DevR was to amplify the gene and incorporate the 
mutation by using 5'-phosphorylated mutagenic primers. The PCR reaction was subjected to 
agarose gel electrophoresis to verify the success of the PCR amplification (as seen in Figure 
4.8 These PCR reactions produced linear plasmids with the mutated genes. Before 
transformation, the linear plasmids had to be circularised. 
 
 
Figure 4.8: PCR products from mutant DevR amplification from M. tuberculosis H37Rv strain. The expected size from 
all four amplifications is 6354 bp. Lane M: MassRuler Express, High range (forward) (Fermentas). Lane 1: K179I. Lane 2: 
K182I. Lane 3: N183L. Lane 4: T205V. 
 
The circularised plasmids were transformed into BL21(DE3) and expression was monitored 
via SDS-PAGE, as seen in Figure 4.9. K179I, K182I, N183L and T205V were used in the 
binding assays with both HspX and NarK DNA fragments. During electrophoresis, the hspX 
and narK DNA fragments were used as negative controls and the shift that takes place when 
phosphorylated wild-type DevR binds to the hspX or narK fragments was used as a positive 
control. In Figure 4.10, the presence of a shift can be seen when K182I and T205V binds to 
the narK fragment. No shift takes place when K179I and N183L were used, indicating that 
binding to the DNA was prevented. The same results can be seen in Figure 4.11 when the 
hspX DNA fragment is used. 
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Figure 4.9: Expression and purification of DevR mutants K179I, K182I, N183L and T205V. Lane M: PageRuler 
Protein Ladder (Fermentas). Lane 1: Purified DevR. Lane 2: K179I (cell free extract). Lane 3: Purified K179I. Lane 4:K182I 
(cell free extract). Lane 5: Purified K182I. Lane 6: N183L (cell free extract). Lane 7: Purified N183L. Lane 8: T205V (cell 
free extract). Lane 9: Purified T205V. 
 
 
 
 
Figure 4.10: Analysis of DevR and mutants binding with NarK DNA fragment. Lane M: O'GeneRuler™ 50 bp DNA 
Ladder (Fermentas). Lane 1: NarK without DevR. Lane 2-4: NarK with DevR. Lane 5-7: NarK with K179I. Lane 8-10: 
NarK with K182I. Lane 11-13: NarK with N183L. Lane 14-16: NarK with T205V. Lane 17-19: NarK with DevR. 
Concentrations of protein are indicated and the DNA concentrations were kept constant. 
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Figure 4.11: Analysis of DevR and mutants binding with HspX DNA fragment. Lane M and 15: O'GeneRuler™ 50 bp 
DNA Ladder (Fermentas). Lane 1 and 11: HspX without DevR. Lane 2-4: HspX with DevR . Lane 5- 7: HspX with K179I. 
Lane 8-10: HspX with K182I. Lane 12- 14: HspX with T205V. Lane 16-18: HspX with N183L. Concentrations of protein 
are indicated and the DNA concentrations were kept constant. 
 
4.3.4 Mass spectrometry  
 
The aim of the MS experiments was to prove the acetyl phosphate does phosphorylate the 
DevR. Radioactively-labelled ATP was used in Chapter 3 to show that DevS201 can 
phosphorylate DevR. No radioactively-labelled acetyl phosphate could be obtained 
commercially, so MS was used to monitor phosphorylation. Phosphorylation causes a 
molecular mass shift of 80 Da. The MS results of the acetyl phosphate-treated DevR showed 
that the protein appears to be phosphorylated at multiple sites, as there is an increase in 
molecular mass in steps of 80 Da, as seen in Figure 4.12. The inspection of DevR revealed 18 
aspartic acids, as indicated in Figure 4.13, these could explain the multiple phosphorylations 
on DevR, as acetyl phosphate phosphorylates at aspartic acids. On the isotopic profiles for 
phosphorylated DevR there are only 14 adducts, which could be explained if solvent 
accessibility, as shown in Figure 4.13 (B), is considered. 
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Figure 4.12: The protein isotopic profiles for phosphorylated DevR (with acetyl phosphate). The first peak is 
unmodified DevR, with an average molecular weight of 25.6805 kDa. A number of modifications can be seen 80 Da apart, 
which is assumed to be various phosphorylation products.  
 
 
Figure 4.13: All aspartic acids in DevR that could potentially be phosphorylated by acetyl phosphate. (A) Highlights 
18 aspartic acids in DevR in yellow, Asp54 is highlighted in pink. (B) Shows that some of the aspartic acids are not solvent 
accessible, this can explain the peaks on the isotopic profiles for phosphorylated DevR. 
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4.4 Discussion 
 
Wisedchaisri et al. (2005) suggested a set of amino acids that could play a role in the binding 
of DevR to the consensus sequence in the promoter DNA of the genes it regulates. The only 
structure available is the truncated C-terminal domain of DevR binding to a 20 bp 
palindromic sequence containing inverted repeats of the GGGACT recognition motif. To 
understand the functionality of binding of DevR to DNA consensus sequences as well as the 
nature of these interactions the following was undertaken: 
EMSA was used to identify sequence specific DNA-protein interactions. Mutation studies 
were used to identify which amino acid residues are involved in the sequence specific DNA-
protein interactions. Mutations were modelled in silico and mutant DevR proteins were 
produced to confirm the effect. 
The structure of the truncated DevR has provided useful insight into the DNA binding in this 
domain, however a structure of the full length DevR interactions is lacking. The full length 
DevR dimerization and DNA binding needs to be investigated. Therefore, a model was built 
of the full length DevR dimer binding to the DNA consensus sequence.  
From the model, it was also postulated that the following amino acids were necessary for 
DevR binding to DNA: K179, K182 and N183. In addition, it was proposed that T205 was 
needed for dimerization. When the mutations K179I, K182I, N183L and T205V were 
modelled, hydrogen bonding side chains were no longer available, the local charge changed 
from partial positive to neutral, and the smaller side chains had a stereochemical influence. 
Subsequently these single mutations were made to DevR and assessed in vitro to validate the 
model.  
The mutated DevR proteins were analyzed in vitro to determine their influence on the binding 
of DevR to DNA. During EMSA analysis of the K179I and N183L mutants, no shift was 
observed, indicating the role of K179 and N183 in DNA binding. Therefore, inhibitors 
interacting with these two amino acids may prevent DevR binding to DNA. The DevR N182 
and T205 mutations still bound to the DNA as the EMSA shift still occurred in assays 
performed using these mutants. Before EMSA can be used as a routine screen there are 
certain shortfalls must be addressed and solved:  
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The loss of binding interactions can be attributed to more than just the loss of electrostatic 
contacts, as hydrogen bonding as well as the inappropriate steric volumes can also play a 
role. 
The DNA did not seem to form a consistent band but rather a smear of DNA fragments. This 
happens when the DNA fragments could not withstand the gel running conditions and 
therefore dissociated from the complexes during electrophoresis. The gel should be run at low 
temperature (+4°C) or at low voltage, to stabilize protein-DNA interactions to decrease the 
smears of fragile complexes (Hellman and Fried, 2007). During these EMSA studies the gels 
were ran at low temperature (+4°C) and the buffer was sufficiently cold as well in order to try 
and prevent the smearing. However, neither lowering the temperature nor decreasing the 
voltage helped to stabilize the complex. 
The shift is not linear. A higher degree of retardation is seen with an increase of the protein 
concentration when the DNA concentration is kept constant. Cicero et al. (1998) experienced 
a similar problem and the conclusion was reached that by using shorter DNA sequences as 
substrates they blocked the slower migrating DNA and linear shifts could be observed. At 
constant protein concentrations, a linear shift would then be seen but with an increase in 
protein concentration, additional DNA or protein interactions may take place that will cause 
the different migration patterns.  
Another explanation for both the smearing and the non linear migration could be that at high 
protein concentrations the equilibrium to binding is for all the DNA to be completely bound 
therefore you see a band high up on the gel. At lower concentrations the equilibrium is 
shifted and more protein is able to dissociate while you are running the gel that is why you 
smearing is observed. Poor resolution may also be due to the detection system, radioactive 
labelling may have improved the results seen. 
Mass spectrometry experiments were carried out to demonstrate the acetyl phosphate 
phosphorylation of DevR. Literature reports that DevR has a molecular mass of 25.5 kDa 
(Saini et al., 2004b). Based on the amino acid sequence NP_217649 (two-component 
transcriptional regulatory protein DevR [Mycobacterium tuberculosis H37Rv]) found in the 
NCBI database, the molecular mass was calculated to be 23.294 kDa. The differences in mass 
between the gene sequence and the expressed protein was as a result of the cloning vector 
that adds amino acids to both ends of the protein. This resulted in an expected molecular 
weight of 25.683 kDa. The MS determined mass was 25.680 kDa. Phosphorylation causes a 
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molecular mass shift of 80 Da. The MS results of the acetyl phosphate-treated DevR however 
shows that the protein is phosphorylated at multiple sites, increasing the molecular mass in 
steps of 80 Da. The phosphorylation of DevR with acetyl phosphate is less specific than 
enzymatic phosphorylation. The inspection of DevR revealed 18 aspartic acids, which could 
explain the multiple phosphorylation of DevR. On the isotopic profiles for phosphorylated 
DevR, there are only 14 adducts, which could be explained if solvent accessibility is 
considered.  
During DNA-protein complex formation, the protein undergoes several conformational 
changes relative to the crystal structure of the native protein. These conformational changes 
were unaccounted for in the models and this could lead to the discrepancies between the 
amino acids identified to bind to DNA in the model, and those that are actually utilized to 
bind the DNA in vitro. Hence, the low level of binding of the DevR mutant enzymes, K182I 
and T205V, is challenging the assumptions of their role in DNA binding, and consequently 
challenging the models built. The role of these amino acid side chains in DNA binding may 
be better explained in higher resolution models and crystal structures. 
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Chapter 5 In vitro protein-protein 
interaction analysis between DevS and 
DevR 
 
 
5.1 Introduction 
 
Specific interactions are involved in almost any physiological process. Protein-protein 
interactions are crucial to the operations of nearly every cellular process, but our 
understanding of interaction specificity is limited. The specificity of two-component 
signalling pathways relies on the intrinsic ability of a histidine kinase to discriminate its 
cognitive response regulator from all other substrates (Puttick et al., 2008). However, 
identifying the amino acids responsible for such molecular level discrimination is difficult 
(Wisedchaisri et al., 2008). Site directed mutagenesis can identify important residues but it is 
often insufficient to discriminate between residues necessary for catalysis and those 
determining substrate selectivity.  
 
5.1.1 Surface Plasmon Resonance (SPR) 
 
SPR is an established and current technique used for biomolecular interaction analysis (BIA) 
(Phillips and Cheng, 2007). Using a SPR biosensor like the BIAcore system, enables the 
measurement of analytes binding to immobilized biomolecules (also called the ligand) 
without using labels (Karlsson, 2004). The BIAcore system (www.BIAcore.com) comprises a 
flow system for continuous buffer and efficient sample delivery along with the real time 
monitoring of complex formation and dissociation of the analyte from the ligand. Ligands can 
be immobilized onto a variety of surfaces using either non-covalent or covalent bonds 
(Willard and Siderovski, 2006). The response units can be quantitatively used to determine 
the reaction rate constants of the binding interaction (Karlsson, 2004). Surface regeneration is 
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done to ensure that the same number of ligand binding sites is available each time a new 
analyte sample is used. Using a range of analyte concentrations should ensure sufficient data 
for curve fitting and rate determination (Karlsson, 2004). The Langmuir equation is used to 
relate binding of the analyte to a ligand as a 1:1 binding model. The equation was developed 
by Irving Langmuir in 1916. 
 
5.1.2 Biosensors 
 
Biomolecular interaction analysis (BIA) is used to resolve the multitude of interconnected 
pathways and systems whose balanced function is essential. Biosensors rely on the specific 
interactions between biomolecules. During binding, a change is observed in different physical 
parameters, such as mass or enthalpy and this can be quantified as interaction kinetics, 
specificity and strength, as well as any conformational changes. Based on literature, the BIA 
market is dominated by BIAcore, whose SPR systems use optical sensors to measure the rate 
of mass addition and removal from which kinetic and affinity parameters can be calculated. 
One the biggest advantages of using the BIAcore is the small amount of ligand and analyte 
needed to obtain valuable information, speed of measurement, real time kinetic analysis as 
well as stoichiometry (Philips and Cheng, 2007). 
 
Figure 5.1 shows a sensorgram produced by the BIAcore system correlated with sensorgram 
events as adapted from Karlsson (2004). When using the biosensor to study biomolecular 
interactions one molecule called the ligand will be mobilized to the sensor chip. The ligand is 
shown in orange in Figure 5.1, with the analyte represented by the green spheres. The analyte 
is washed over the ligand and the interaction measured. 
The degree of binding of the ligand to the sensor chip is measured in Response Units (RU) 
and after immobilization a baseline is established; when the analyte binds to the ligand this 
interaction is also quantified in RUs (Philips and Cheng, 2007). The kinetics of an interaction 
is based on the rates of association (ka) and dissociation (kd). The values of ka and kd are 
determined by fitting the RU data to the 1:1 Langmuir model. The equilibrium dissociation 
constant KD is calculated by the ratio of the kinetic rate constants (kd/ka), measured in M. 
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High affinity interactions is defined by KD<10 nM and weak affinity interactions are defined 
by KD>100 µM. 
 
 
Figure 5.1: The sensorgram and sensorgram events. Initially the ligand (orange spheres) is mobilized to the sensor chip, 
and a baseline level indicated by the red dotted line is established. The analyte sample (green spheres) is injected and 
complex conformation occurs during the sample response. After the sample injection stops, the analyte starts to dissociate, a 
regeneration solution can be injected to speed up the dissociation process and restore the surface for further experiments. 
 
5.1.3 Rate equations for 1:1 kinetics 
 
When studying biomolecular interactions using a biosensor, the phase during which analyte is 
being injected and a complex is formed with the bound ligand, is labelled the 'association 
phase', while the period following the end of the injection is termed the 'dissociation phase'. 
Equilibrium is reached when the association rate equals the dissociation rate. The kinetics of 
an interaction based on the rates of association (ka) and dissociation (kd) can be determined, 
as seen from Figure 5.2. A is the analyte in solution, whose concentration is maintained by a 
constant flow system. B is the ligand on the surface. Total concentration can be expressed in 
RU. AB is the complex where the concentration of complex is also measured directly in RU.  
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Figure 5.2: Rate equations for 1:1 kinetics. A is the analyte in solution, a constant concentration is maintained via the flow 
system. B is the ligand on the surface. Total concentration can be expressed in RU. AB is the complex where the 
concentration of complex measured directly in RU. 
 
5.1.4 Protein-protein interactions between DevS and DevR 
 
Two-component histidine kinases play a significant role in the regulation of bacterial 
homeostasis. This is especially true in disease causing organisms such as Mycobacteria 
tuberculosis. Two-component signalling represents an excellent system for probing the 
molecular basis of specificity in a large paralogous signalling family. This study is 
particularly valuable because no high-resolution structures are available for full length or 
truncated DevS in complex with DevR. The overall aim of the project is to identify a novel 
mechanism to target tuberculosis in a rational drug design program. If DevR and DevS 
binding are to be used in a drug development program it is essential to have the protocols to 
accurately measure their interaction in addition to develop a fundamental understanding of 
how their interactions occur. The question remained as to whether DevS201 has the same 
binding affinity to DevR in comparison to DevS. These experiments will explore the 
difference in binding affinity of DevR to both DevS and DevS201. 
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5.2 Methods 
 
5.2.1 Ligand immobilization 
 
All the experiments were conducted on a BIAcore 3000 instrument (Stevenage, United 
Kingdom), using the HBS-N buffer for the CM5 biosensor chip (research grade; BIAcore) 
with a carboxylmethyl dextran surface. The temperature was maintained at 25°C during the 
whole experiment. The DevS or DevS201 proteins were immobilized to the surface using 
amine coupling through lysine residues following the standard protocol, as explained. The 
carboxymethyl groups were activated with 0.2 M EDC and 0.5 M NHS, thus creating highly 
reactive succinimide esters which react with amine and other nucleophilic groups on proteins. 
The second step was the coupling step during which ligand is injected into the flow cell at a 
buffer pH which causes the proteins to be positively charged, thereby driving the electrostatic 
interactions with the negatively charged carboxylated dextran matrix. To optimize binding, 
the reaction takes place in a buffer with a pH below the protein’s isoelectric point, yielding a 
net positive charge. Both DevS and DevS201 bound optimally in 10 mM sodium acetate, 
pH 3.5. During the final blocking step, the activated carboxymethyl groups that are not 
involved in ligand binding were neutralized by very high concentrations of ethanolamine 
(1 M ethanolamine, pH 8.0), which would elute any non-covalently bound material.  
Following analysis, a regeneration step was carried out to remove the analyte from the ligand 
so the surface may be re-used. For regeneration, 10 mM glycine at pH 2.5 was used. 
 
5.2.2 DevR binding analysis 
 
The affinity of the interaction between response regulator (DevR) and the sensor kinase 
(DevS or DevS201) was measured on a BIAcore 3000 instrument. The bound ligand and 
analyte were measured as a change of the refractive index, recorded in RU (Joubert et al., 
2010). The temperature was maintained at 25°C during the whole experiment and the flow 
rate at 1 µl/min (Dey et al., 2005). The proteins were immobilized to the surface using amine 
coupling through lysine residues following the standard protocol (Karlsson et al., 2004, 
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Joubert et al., 2010). In order to perform kinetic analysis, the ligand (either DevS or 
DevS201) was immobilized at three different concentrations in three different flow cells. 
Measured in RU, for DevS, the concentrations were 11,489.37 RU, 12,598.42 RU and 
13,731.07 RU. For DevS201, they were 7,144.61 RU, 10,735.60 RU and 12,665.33 RU. 
DevR (analyte) was prepared at a range of concentrations (100 to 2,000 nM). A 75 µl sample 
was injected (KINJECT procedure) at 5 µl/min using an association time of 300 seconds, 
followed by 10 µl of 10 mM glycine (pH 2.5) with a 300 second dissociation. Injection of the 
analyte was initially done starting from lower concentrations to the highest concentrations, 
and then repeated by starting at the highest concentration going down to the lowest. Analyses 
of association and dissociation curves were performed using BIAevaluation 4.1 software 
(BIAcore) by the so-called global method. The data were fitted to the 1:1 Langmuir model. 
The dissociation (kd) data were fitted first, followed by the complex formation (ka) data, both 
done globally. For the DevS201 analysis, 9 curves were fitted for the following analyte 
concentrations: 100 nM, 200 nM, 250 nM, 375 nM, 500 nM, 750 nM, 1000 nM, 1,500 nM 
and 2,000 nM. For DevS, 10 curves were fitted for the following analyte concentrations: 100 
nM, 125 nM, 200 nM, 250 nM, 328 nM, 656 nM, 750 nM, 1,312 nM, 1,500 nM and 2,000 
nM). The affinity of binding (KD) was determined by the ratio of the kinetic rate constants, 
kd/ka. 
 
5.3 Results 
 
During the BIAcore analysis two methods of ligand immobilization were considered: NTA 
immobilization for His6-tagged proteins and amine coupling. Initially, the NTA coupling was 
considered since the Dev proteins were already His6-tagged for purification. Unfortunately a 
common deficiency of NTA-immobilized proteins is the slow and continuous dissociation of 
the proteins from the surface (Willard and Siderovski, 2006). A secondary problem was that 
both the ligand and the analyte were His6-tagged, increasing non-specific binding because the 
analyte will bind to the chip surface and not specifically to the ligand. The BIAcore system is 
unable to measure the difference. Consequently, amine coupling was successfully used to 
bind DevS and DevS201 onto the chip.  
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The success of the amine coupling was measured in RU units, and if the coupling was 
unsuccessful the binding would be very low, approximately  7,000 RU. Values above this are 
regarded as successful binding. The kinetics of an interaction, and the rates of association (ka) 
and dissociation (kd), can be determined from the information in a sensorgram such as that 
shown in Figure 5.3, obtained for one of the flow cells with DevS as ligand. Using the data 
obtained, the KD was calculated to be 255 nM for DevS201 and 184 nM for DevS. This was 
an average from the three flow cells with different concentrations of bound ligand. The data 
were reproducible from one flow cell to another with a standard deviation of 0.06 (DevS) and 
0.31 (DevS201). These KD values show that the truncated DevS201 has a similar affinity to 
the full length DevS for DevR. A Student’s t-test was done on the data and found to be 0.019. 
 
 
 
Figure 5.3: Overlay plots of sensorgram of DevS interactions of various concentrations of DevR. The following 
concentrations are shown on the graph: 100 nM (blue), 250 nM (pink), 656 nM (green), 750 nM (orange) and 1,500 nM 
(purple). The increase in signal is indicative of the association that is taking place, the quick drop is the due to the change in 
buffer and the slow decrease in signal is the dissociation taking place. 
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5.4 Discussion 
 
Sensor kinases are membrane-bound with abundant transmembrane regions, which influences 
solubility during in vitro expression and purification. It is therefore possible that the absence 
of these regions in DevS201 could induce conformational changes during in vitro refolding. 
The consequential aim of this research was to determine the effect of the truncation of DevS 
on its binding to DevR, to establish whether DevS201 can be used in future binding and in 
silico modelling studies.  
When binding takes place, the response in the sensorgram increases. The binding orientation 
of DevS to the chip can compromise the DevR binding site, however the RU values indicated 
that protein-protein binding did take place. Once equilibrium is reached, a constant signal is 
seen. Dissociation of the bound molecules causes the response to decrease. BIAcore 
evaluation software generated the values of ka and kd by fitting the data to the 1:1 Langmuir 
model. The affinity of binding is determined by the equilibrium constant, KD. KD is 
calculated by the ratio of the kinetic rate constants, kd/ka. Using the data obtained, the KD 
was calculated to be 255 nM for DevS201 and 184 nM for DevS. It is evident that the 
truncated DevS201 binds moderately better to DevR than DevS. The lower the KD, the 
higher affinity the ligand has for the analyte. Changes in protein conformation could 
influence the accessibility of the DevR binding regions, thereby interfering with binding. 
DevS201 comprises the soluble cytosolic catalytic core; the loss of binding activity could be 
linked to changes in conformation due to truncation.  
The kinetic constants obtained were compared to other reported biosensor-derived constants 
for TCSs. During biosensor experiments done by Perraud et al. (2000), the authors found that 
EvgA showed a very weak interaction with the kinase domain of EvgS, with an affinity 
constant of 806 nM. A stronger affinity was found between HupT and HupUV, with a KD of 
430 nM (Elsen et al., 2003). Two other studies also had KD values in the nanomolar range: 
the VanSR system had a KD 30 nM, (Fisher et al., 1996) and CheAY had a KD of 30 nM 
(Schuster et al., 1993). The KDs determined for DevS and DevS201 were also in the 
nanomolar range, at 184 nM and 255 nM, respectively. For sufficiently strong binding 
between a histidine kinase and a response regulator, the KD needs to be in the nM range. 
Therefore it can be concluded that DevS201 binds DevR strongly enough to be used in future 
studies. The low consumption of target proteins as well as the sensitivity for detection of low-
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affinity binding confirms that the BIAcore system is an excellent way of studying complex 
drug interactions. Hence the BIAcore could be used to screen small-molecule inhibitors of 
DevR-DevS interactions and potentially DevR-DNA binding as well.  
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Chapter 6 Concluding discussion 
 
The focus of this study was to investigate the binding interactions of Mycobacterium 
tuberculosis Dev two-component system with the aim of identifying potential loci for drug 
design. The following facets were investigated:  
 
The basic biochemistry of the TCS starts with DevS’s capability to recognize the change in 
the environment, autophosphorylation and subsequent phosphorylation of DevR. 
Accordingly, if phosphorylation is blocked by any mechanism it will have a detrimental 
effect on the Dev TCS system's control of the dormancy regulon. The protocols that were 
developed in testing the efficiency of DevS and DevS201 phosphorylation can be used to 
screen inhibitors designed to block phosphorylation. The identification of lead molecules that 
inhibit phosphotransfer is an avenue that is relatively unexplored for inhibitor screening. 
 
To facilitate phosphorylation, the DevS-DevR complex formation is vitally important. 
Protein-protein docking provides us with a series of candidate structures for the DevS201-
DevR complex. The native structure can only be corroborated if the complex is crystallized 
and the structure determined. The expression of high concentrations of all the components of 
the Dev TCS was achieved. This paves the way for future crystallization or NMR studies to 
elucidate the specific amino acids that play a role in the complex formation. High throughput 
screening can be used to find a drug that will target protein complex formation. 
Consequently, a protocol using the BIAcore SRP technology was developed to quantify 
DevR and DevS binding. It was established that this method is sensitive enough to be used in 
high throughput screening. It also proved that the truncation of DevS did not compromise the 
binding constant significantly. Since the protocol for DevR binding to both DevS and 
DevS201 was effectively achieved, one can modify this screen to incorporate DevT as well. 
Based on the BIAcore results, it was also concluded that using DevS201 in the structural 
design strategies will give us a near native presentation of the DevS-DevR complex. This 
assumption is supported by the results obtained from the phosphotransfer assays, where 
DevS201 is able to phosphorylate DevR as efficiently as the full length DevS. 
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Financial constraints were the biggest issue in repeating these experiments with the DevR 
mutants. Because the experiments needed to run in triplicate to make the results statistically 
significant three chips was used to do the DevR-DevS interaction analysis. This means that 
an additional 3 chips were needed to test each mutant. The stability of the immobilized 
protein becomes questionable after a specified amount of runs and consequently the DevS 
mobilized for the DevS-DevR interactions could not be re-used efficiently. In conclusion, it 
was not financially possible for us to obtain another 12 chips to test the mutant DevR. It 
would have been a great contribution to the thesis if it was possible to study the DevR mutant 
interactions with DevS using BIAcore. Future work should include testing the DevR mutants 
especially the T205 mutant. 
 
After DevR is phosphorylated, the activated response regulator induces the dormancy regulon 
by interacting with specific palindromic DNA sequences that precedes the genes of the 
regulon. Compounds that inhibit DevR binding to target DNA can down-regulate dormancy 
gene transcription, and drastically reduce survival of hypoxic bacteria (Gupta et al., 2009). 
The model of the DevR binding to DNA gave us an insight into the amino acids used for 
binding. K179I and N183L were identified as amino acids that can be used as targets in a 
structure-based drug design strategy. SDMs of these amino acids confirmed this and can be 
used in future to map the exact DNA binding site. The EMSA protocol developed here can be 
used routinely to screen for inhibitors against DevR-DNA binding.  
 
The intention was to investigate the binding interactions of DevS-DevR, with the aim of 
improving our understanding of the detailed mechanism associated with M. tb latency and 
conceivably provide good drug targets for persistent tuberculosis. In conclusion four different 
aspects were identified as drug target against the Dev TCS: The autophosphorylation of 
DevS, the phosphorylation of DevR by DevS, binding interaction between DevR and DNA, 
and DevS and DevR complex formation. 
 
Many response regulators can be phosphorylated albeit less efficiently by low molecular 
weight phosphor donor such as acetyl phosphate (McCleary and Stock, 1994). Since 
phosphorylated DevR rapidly loses its phosphosignal in the presence of both DevS and DevT, 
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the DevR was phosphorylated using acetyl phosphate. This was done to ensure reproducible 
results that were only dependent on one protein species rather than adding the additional 
variability of a second protein species to the assay. 
 
Preventing the signal transduction system between the histidine kinase and the reaction 
regulator could thus prevent the establishment of dormancy of people infected by M.tb. 
Consequently by establishing assays to indentify inhibitor that will either block the 
phosphotransfer or dimerization will be more relevant to the drug discovery process. The his-
asp signal transduction pathways are distinctly different from the pathways seen in humans 
hence drugs that will inhibit the Dev TCS are expected to specifically target bacteria. The 
handling of radioactive isotopes is a perceive disadvantage to studying the phosphotransfer 
interactions. By using the BIAcore system this will be circumvented but ultimately enabling 
the rapid screening of molecules that will prevent the signal transduction by intervening with 
the DevR and DevS binding. The inherent difficulty in targeting the Dev TCS is that both 
DevS and DevT can phosphorylate DevR  
 
Although the signal transduction seems to be the superior target due to its specificity, DevR 
has merits as a drug target as well because of its key role it plays in the signalling cascade. 
Consequently multiple signalling systems could be inhibited by a single molecule if the DevR 
binding interactions with DNA could be prevented. Developing high throughput assays based 
on EMSA might be more difficult. 
 
It would therefore be an optimal situation if one could combine the findings of this study into 
one solution. The BIAcore was the instrument that worked the best in terms of quantitative 
measuring of binding interaction and by proxy also inhibition. However, targeting the 
response regulator will interfere with pathways that are vital for M. tb survival, in the host. 
For future studies it would be worthwhile investigating the ability to study the DevR DNA 
binding interactions using the BIAcore system.  
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In conclusion, this investigation provided significant insights into the molecular basis of 
dormancy as regulated by the Dev TCS. The investigation into both the protein-protein 
interactions as well as the DNA-protein interactions provides a set of drug targets that can be 
used against persistent tuberculosis. A more detailed rational drug design program can now 
be put into place. 
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